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resumo 
 
 
Inúmeras potenciais funções foram sugeridas para a APP (Proteína Precursora 
de Amilóide de Alzheimer), contudo, fisiologicamente, a função precisa da APP 
não foi ainda desvendada. A APP tem características consistentes com a 
função de molécula-receptora, capaz de reconhecer sinais extracelulares. 
Também relevante para este trabalho, é o facto de que a sinalização através 
de RIP (Proteólise Intramembranar Regulada) tem consequências na 
expressão génica, como no caso da sinalização tipo-Notch. Tal como a 
proteína Notch, a APP é processada resultando num fragmento C-terminal 
designado por AICD (Domínio Intracelular da APP). Neste trabalho é focado o 
papel importante na sinalização nuclear desempenhado pelo fragmento AICD, 
especificamente através da interacção com proteínas adaptadoras, 
promovendo a transcrição. Com o objectivo de contribuir para uma melhor 
compreensão da base molecular da DA (Doença de Alzheimer), torna-se 
importante investigar as vias de localização nuclear do AICD e o seu 
envolvimento na transcrição génica, possivelmente afectando proteínas até 
agora não associadas à DA. Por estes motivos é fundamental a identificação 
de novas proteínas que interajam com a APP. 
Um rastreio foi efectuado, utilizando o sistema Dois-Híbrido em Levedura, para 
identificar interacções específicas do AICD no cérebro humano e, assim, 
caracterizar o interactoma do AICD. Foi feito o rastreio de aproximadamente 
1.1x108 clones de uma biblioteca de cDNA de cérebro humano com o domínio 
C-terminal da APP com a mutação Y687E, que mimetiza o estado fosforilado. 
De experiências anteriores deste laboratório sabemos que a tirosina-687 
afecta a localização subcelular da APP e é também consensual que a 
fosforilação é importante nos mecanismos de transdução de sinais, daí a 
utilização deste mutante parecer apropriada. 
O rastreio originou 55 clones positivos que foram analisados para identificar 
proteínas que interagem com a APP. Dois clones são particularmente 
importantes, a RanBPM e a Transportin-SR2, visto que estão associadas ao 
transporte de proteínas para o núcleo e confirmam a sinalização nuclear da 
APP. 
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abstract 
 
Many putative functions for APP (Alzheimer’s amyloid precursor protein) have 
been suggested, although the precise physiological function of APP remains to 
be elucidated. APP has characteristics consistent with it having a role as a 
receptor, capable of mediating extracellular signals. Also of relevance to the 
work described here is that RIP (Regulated Intramembrane Proteolysis) 
signalling can have consequences in gene expression, similar to Notch 
signalling. Like the latter, APP is processed by RIP resulting in a C-terminal 
fragment known as AICD. Here we test the hypothesis that the AICD fragment 
may play an important role in nuclear signalling, specifically by interacting with 
adaptor proteins potentiating transcription. Therefore, in order to contribute to 
our understanding of the molecular basis of AD (Alzheimer’s disease) it is 
important to investigate the pathways of AICD nuclear targeting and its 
involvement in gene transcription, possibly affecting other proteins hitherto not 
associated with AD. Thus, it is important to identify AICD binding proteins. 
A Yeast Two-Hybrid (YTH) screen was performed to identify human brain-
specific AICD binding proteins, and thus characterize the AICD interactome. 
The screen of approximately 1.1 x108 clones from a human brain cDNA library 
was carried out using the AICD fragment with an Y687E mutation, which 
mimics phosphorylation on that residue. From previous work carried out in the 
laboratory we know that tyrosine-687 phosphorylation affects subcellular 
localization of APP, and it is also recognized that phosphorylation events are 
important in signal transduction mechanisms, hence the use of this mutant is
appropriate. 
The YTH screen yielded 55 positive clones that were analysed and several
novel brain-specific APP binding proteins were identified. Two clones were 
particularly important, RanBPM and Transportin-SR2, being that they are 
associated with the nuclear transport of proteins, and support the nuclear 
signalling for APP. 
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I INTRODUCTION 
 
 
I.1 THE YEAST TWO-HYBRID SYSTEM  
 
 
Principles of the Yeast Two-Hybrid System 
 
The Yeast Two-Hybrid system is a method that allows the identification of a 
large number of proteins capable of interacting with a protein of interest. A large 
number of clones can be simultaneously tested using a cDNA expression library 
selected from a particular tissue. To identify brain-specific APP binding proteins 
we selected the Yeast Two-Hybrid System, using the APPY687E specific intracellular 
domain as bait for the screening of a human brain cDNA library. 
The yeast two-hybrid system (YTH), was initially developed as a simple 
method to probe protein-protein interactions (Fields and Song, 1989; Fields and 
Sternglanz, 1994). It takes advantage of the modular architecture of eukaryotic 
transcription activators, which comprise two functionally independent domains: a 
DNA-binding domain (BD) that recognizes a specific DNA sequence in the 
promoter region and a DNA-activation domain (A ctD) that brings the 
transcriptional machinery to the promoter proximity, leading to expression of the 
gene. 
The independence of DNA-BD and ActD domains was demonstrated by 
fusing the ActD of yeast GAL4, a yeast transcription factor involved in galactose 
metabolism, with the DNA binding domain (BD) of E. coli LexA (a bacterial 
repressor involved in the control of damage inducible genes) to create a 
functional transcription factor in yeast (Brent and Ptashne, 1980). Fields and Song 
used it to prove an interaction between two known proteins, by fusing GAL4-ActD 
to a protein X (prey) and GAL4-BD to a protein Y (bait) (Fields and Song, 1989). 
These two elements can be cointroduced into yeast strains modified with one or 
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more reporter genes (the use of multiple reporter genes decreases the number of 
false positives obtained). These reporter genes have a binding site specific to the 
BD on their promoter region, causing the transcription of those genes to be 
dependent on the interaction between prey and bait proteins. Interaction of the 
BD/bait fusion with the ActD/prey fusion positions the ActD in the proximity of the 
reporter gene, thus activating its transcription (Fig. I.1) (Causier and Davies, 
2002). 
 
 
 
Figure I.1: The yeast two-hybrid system. Two hybrid proteins are expressed in yeast: a) 
GAL4 DNA-binding domain (BD) fused to a bait protein and GAL4 activation domain (ActD) 
fused to a prey protein. The BD-bait hybrid protein can bind to upstream activation sites 
(UAS) but cannot activate transcription. b) The ActD-prey protein cannot recognize the 
UAS, thus, alone is not capable of initiating transcription. c) When the bait and the prey 
interact, the BD and ActD are brought together and can activate reporter gene 
transcription. 
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The reporter genes used in this screen are the MEL1 gene (coding for ? -
galactosidase, that is secreted into the culture medium) and auxotrophic genes 
HIS3 and ADE2, that allow these yeast strains to grow in medium lacking histidine 
and adenine. The nutritional selection reporter genes allow for easy recovery of 
interacting clones in large screening procedures, using a cDNA library, designed to 
identify new interacting proteins with a selected bait. Additionally, the YTH bait 
plasmid pAS2-1 and the library plasmid pACT2, which contain the TRP1 and LEU2 
genes, respectively, allow for selection in medium lacking tryptophan and leucine. 
Hence, the high-stringency selection consists of medium lacking tryptophan, 
leucine, histidine and adenine, and also in the presence of X-? -Gal. The selection 
of positive clones with the five reporter genes TRP1, LEU2, HIS3, ADE2 and MEL1 
(Matchmaker Yeast Two-Hybrid System 2, Clontech) was designed to reduce the 
number of false positives, thus allowing faster identification of true interactions 
with the bait protein. 
Larger scale two-hybrid approaches typically rely on interaction mating 
(Serebriiskii et al., 2001). In this method a yeast strain expressing the bait protein 
is mated with another yeast strain of opposite mating type pretransformed with 
the cDNA library. Interaction between two proteins can then be determined by 
the activation of one or more reporter genes in the diploid strain. One advantage 
of this approach is the possibility of using frozen aliquots of pretransformed yeast 
cells saving time and resources. An additional benefit of using yeast mating is that 
diploid cells are more tolerant to expression of toxic proteins and less false 
positives will appear since the diploids have reporter genes less sensitive to 
transcription (Kolonin et al., 2000). 
Over the 14 years since its introduction this system has been modified 
greatly expanding its biological and technological applications. The YTH has been 
developed first as an agent of biological discovery, second as a tool in proteomics 
and finally as a means towards engineering novel pharmaceutical agents. Some 
alternative YTH systems have been developed and in many cases resulted in 
remarkably elegant hybrid systems (Serebriiskii et al., 2001; Tyree and Klausing, 
2003; Causier, 2004). 
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Limitations of the YTH 
 
Although the YTH system has been widely used both to demonstrate and 
to identify novel protein interactions with proteins from multiple sources, from 
prokaryotes to plants and mammals, this system has some intrinsic limitations 
that should be considered. It relies on yeast expression of two hybrid proteins and 
on their action as transcription factors in the yeast nucleus being dependent on 
their interaction. Limitations exist if one of the proteins cannot be expressed, 
folded or post-translationally modified in yeast cells, or if the GAL4 fusion impairs 
correct folding. In fact yeast doesn’t possess all the post-translational machinery 
needed and toxicity problems may occur. Also, if any of the fusion proteins are 
capable of activating reporter gene transcription, false positives will arise. One 
also has to bear in mind that a legitimate protein-protein interaction may have no 
functional significance if it involves two proteins that never co-localize in 
physiological systems (e.g. that are expressed in different tissues). Other causes 
which may also lead to false results are the inability of fusion proteins to migrate 
to the nucleus. 
The limitations of the YTH system do not exclude it from protein networks 
research, but reinforce the need to validate all the interactions. These should be 
tested in different systems, preferably, by confirming the physical association of 
the native proteins in the cell where the functional interactions are predicted to 
occur. Nevertheless, it is important to remember the usefulness of the YTH in the 
construction of large interaction networks, and in identifying unsuspected 
interactions that may latter be confirmed by a variety of independent methods. 
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I.2 ALZHEIMER’S AMYLOID PRECURSOR PROTEIN 
 
 
I.2.1 Alzheimer’s amyloid precursor protein structure 
 
The Alzheimer’s Amyloid Precursor Protein (APP) is a type I transmembrane 
glycoprotein consisting of a large extracellular domain, a single transmembrane 
domain, and a short cytoplasmic tail. Following proteolytic processing, APP gives 
rise to the Abeta peptide, the major component of Alzheimer’s amyloid plaques 
(Haas et al., 1995). The mammalian APP superfamily comprises three members: 
APP and the APP-like proteins APLP1 and APLP2 (Wasco et al., 1993a; Wasco et 
al., 1993b; Wasco et al., 1993c), which are functionally and structurally related, 
and share similar functions (Coulson et al., 2000).  
The human APP gene is localized to chromosome 21 (21q21.2-3) and 
contains 19 exons, with the Abeta sequence as part of exons 16 and 17 (Turner 
et al., 2003). Alternative splicing of exons 7, 8 and 15 of the APP mRNA produces 
eight isoforms, ranging in size from 677-770 aa (L-677, 695, L-696, 714, L-733, 
751, L-752, 770) (Tanzi et al., 1993). APP is ubiquitously expressed in mammalian 
cells with a broad tissue distribution. The three major APP isoforms are the 695, 
751 and 770. APP695, the exon 7-excluding isoform, is the most highly expressed 
in neurons (Goedert and Crowther, 1989; Tanzi and Hyman, 1991; LeBlanc et al., 
1997). 
 
 
I.2.2 Trafficking and proteolytic processing of APP  
 
The pathological cascade leading to clinical manifestations of AD has not 
been completely characterized although the “? -amyloid hypothesis” has been 
used to explain certain aspects of AD. According to this hypothesis, the 
accumulation of the A?  peptide, which derives from the proteolytic processing of 
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APP, is the primary event that leads to all subsequent events in the pathology of 
AD (Hsiao et al., 1996; Golde, 2002). 
APP is synthesized on membrane-bound polysomes and matures as it is 
transported through the secretory pathway, becoming N- and O-glycosylated and 
tyrosyl-sulfated while moving through the trans-Golgi network. Immature APP 
(being N-glycosylated only) may be cleaved in the endoplasmic reticulum or the 
cis-Golgi but the mature APP is degraded rapidly as it is transported to or from 
the cell surface via either a biosynthetic or endocytic pathway (De Strooper et al., 
1993; Hartmann et al., 1996; Selkoe, 2001). 
 
 
 
Figure I.2: Proteolytic processing of APP. Non-amyloidogenic pathway: ? -secretase 
cleaves APP within the Abeta region preventing its formation and originating the sAPP?  
fragment. The C-terminal fragment is then processed by ?-secretase to p3 and the AICD 
fragments. Amyloidogenic pathway: ?-secretase cuts APP N-terminally to the Abeta 
region and produces the sAPP? fragment. The CTF is further cleaved by ?-secretase to 
Abeta and AICD. 
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APP metabolism is complex, and can occur via several pathways, becoming 
an important area with respect to the generation of Abeta, which is deposited in 
the AD brain. APP comprises three main proteolytic sites, that correspond to ? -, 
? - or ?-secretases (Esler and Wolfe, 2001), being the cleavage sites therefore 
denoted ? , ?  and ? sites. The majority of mature APP is proteolytically cleaved via 
one of two competing pathways, the non-amyloidogenic and the amyloidogenic 
pathway (Fig. I.2), according to the ? - or ? -cleavages occurrencing (Nunan and 
Small, 2002). Alpha and beta-secretases cleave APP at the beginning or in the 
middle of the Abeta sequence and liberate a large fragment (secreted APP or 
sAPP) from the extracellular domain of the protein, named ? sAPP and ? sAPP, 
respectively. The remaining portion of APP is called the ? -carboxy-terminal 
fragment (? CTF or C83), or the ? -carboxy-terminal fragment (?CTF or C99).  
Subsequent to the first ? - or ? -cleavage, ?-secretase cleaves APP either at 
the ?-site or at ?-site (Fig. I.3) and peptides of different lengths may be 
generated. Although both ?-site ?-site cleavages are independent, they are 
believed to occur nearly simultaneously. Processing of ? CTF by ?-secretase, 
generates a short peptide termed p3 (3kDa), which lacks the Abeta 17 N-terminal 
amino acids (Turner et al., 2003). 
When processed by ?-secretase, ? CTF generates predominantly Abeta 1-40 
or 1-42 fragments (Haass et al., 1992; Johnson-Wood et al., 1997). Abeta species 
spanning from 1-39 to 1-43 amino acid long can also be produced, with Abeta 
fragments appearing to be more amyloidogenic with increasing length. ?CFT 
cleavage should release both A? 40-42 and APP C-terminal fragments of 59-57 aa 
long, respectively. Unexpectedly, the purified and sequenced C-terminal fragment 
of APP, termed AICD (APP intracellular domain), is 7-9 aa shorter, consisting of 50 
residues, which remains to be explained (Sastre et al., 2001; Koo, 2002). 
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Figure I.3: APP cleavage by ? -secretase prevents Abeta generation. In contrast, 
sequential cleavage of APP by ?-secretase and ?-secretase results in the production 
of 40 - 42 amino acid long Abeta (depending on where the ?-secretase cleavage 
occurs). The major cleavage sites of APP secretases are: Met-596 for ?-, and Lys-
612 for ? -secretases, and Val6-36 (?-site) and Leu-645 (?-site) for ?-secretase 
(APP695 numbering) (adapted from (Russo et al., 2005)).  
 
 
? -secretase 
 
? -secretase cleaves APP within the Abeta region, close to the APP 
membrane-spanning domain (Lys613-Leu614, APP695 numbering). As described 
above, cleavage at this site (Fig. I.3) prevents A?  generation and produces a 
soluble protein of 612 aa, ? sAPP (Esch et al., 1990). Three candidates have been 
identified for search for ? -secretase. The first was the tumor necrosis factor alpha 
converting enzyme (TACE or ADAM 17), a disintegrin and metalloprotease  that 
releases tumor necrosis factor from its receptor form (Hooper and Turner, 1995; 
Esler and Wolfe, 2001; Capell et al., 2002). The other candidates are also 
members of the metalloproteases ADAM family: ADAM 10 and MDC9. Like TACE, 
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they are initially expressed as inactive preproteins and their active forms can also 
affect ? sAPP levels (Koike et al., 1999; Lammich et al., 1999).  
 
 
? -secretase 
 
The site of ?  cleavage (? -site) occurs between residues 596 and 597 of 
APP695, exactly at the N-terminus of the Abeta sequence (Fig. I.3), and releases 
the ? sAPP of 595 aa long. Furthermore, the levels and activity of ? -secretases 
were found to be increased in AD (Fukumoto et al., 2002). The enzymes that 
cleave at the ? -site have been identified as the aspartyl proteases ? -site APP 
cleaving enzyme 1, BACE1 (Vassar et al., 1999; Hussain et al., 2000), and ? -site 
APP cleaving enzyme 2 (BACE2) (Farzan et al., 2000). BACE1 and BACE2 are both 
membrane-anchored enzymes that are expressed in neuronal tissues, although 
BACE2 expression is lower than BACE1. Like all aspartic proteinases BACE1 and 
BACE2 are generated as proenzymes, and while the BACE2 activation by 
prodomain processing is autocatalytic, BACE1 activation is mediated by furin or a 
furin-like enzyme (Hussain et al., 2001). The third candidate identified for ? -
secretase was Carboxypeptidase B, which, in contrast to BACE enzymes, lacks a 
transmembrane domain. It is a soluble enzyme located in the cytosol of various 
neurons and some microglial cells (Matsumoto, 2000). 
 
 
?-secretase 
 
?-secretase, which cleaves ? CTF and ? CTF C-terminally to the A?  region, 
within the APP transmembrane domain, is a multicomponent enzymatic complex 
(Wolfe et al., 1999). The two prime candidates for the ?-secretase are presenilin-1 
(PS1) and presenilin-2 (PS2), both initially identified by genetic linkage analysis of 
non-APP familial AD mutations that increased Abeta 1-42 in humans, and mapped 
to chromosomes 14 and 1, respectively (Clark et al., 1996; Cruts et al., 1998). 
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PS1 and PS2 are integral membrane proteins with at least eight transmembrane 
domains (Thinakaran et al., 1998). PS2 seems to be responsible for fewer CTFs 
cleavages than PS1. Nonetheless, there might be multiple ?-secretase enzymes 
with varying degrees of selectivity for producing Abeta 1-40 and Abeta 1-42 (De 
Strooper et al., 1999; Wolfe, 2001). Another component of ?-secretase is Nicastrin 
(NCT), which also affects the complex’s enzymatic activity (Esler et al., 2002), and 
interacts both with APP CTFs and PS1 and PS2. Nicastrin contains a single 
transmembrane domain, is extensively glycosylated and has four conserved 
cysteine residues at the extracellular  N-terminus. Mutations within a conserved 
region of nicastrin lead to enhanced Abeta secretion, while deletion of the same 
region prevents Abeta secretion (Yu et al., 2000). Two other proteins were 
identified as ?-secretase subunits: APH-1 or APH-2 (with APH-2 being only 
relevant in cerebral tissues ?-secretase activity) and PEN-2. Recent reports show 
that ?-secretase is indeed an aspartyl protease complex composes of the four core 
components APH-1, nicastrin, presenilin-1 and presenilin-2 (Capell et al., 2005). 
 
 
Caspase-cleveage of APP 
 
Additional reports have revealed that APP can also be proteolytic processed 
at it C-terminus by caspases like caspase-3, caspase-6, caspase-8 or caspase-9 
(Pellegrini et al., 1999; Soriano et al., 2001). The target residue for the caspase-
directed APP cleavage is Asp664 (APP695 numbering) (Weidemann et al., 1999). 
The resultant C-terminus C31 (Fig. I.3) peptide is a potent inducer of apoptosis, 
and this cleavage was shown to reduce APP internalization but to have varying 
effects on the Abeta secreted levels (Soriano et al., 2001).  
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I.2.3 Putative functions of APP and its derivates 
 
 
Functions of full-lengh APP 
 
Although the precise function of APP is unknown, it is probably involved in 
the development of the nervous system. Transgenic mouse studies revealed that 
knockout of the APP gene has only mild effects on neuronal function (Seabrook et 
al., 1999). However, triple knockout of APP, APLP-1 and APLP-2, results in 
abnormal layering of the cerebral cortex (Herms et al., 2004), suggesting that the 
APP family proteins are critically involved in the development of the nervous 
system. The transmembrane structure of APP is consistent with a role as either a 
receptor or a mediator of extracellular interactions. It has also been suggested 
that APP may have CAM (Cell Adhesion Molecule) and SAM (Substrate Adhesion 
Molecule) like activities. In fact, APP possesses several domains (Fig. I.4) that 
promote binding to specific substrates, such as heparin and collagen, which 
implicate cell-surface APP in both cell-cell and cell-substrate adhesion (Breen, 
1992; Multhaup, 1994). The binding of heparan sulfate proteoglycan to heparin 
binding domain stimulates the neurite outgrowth-promoting effects of APP (Qiu et 
al., 1995). In fact the heparan sulphate proteoglycan glypican-1 has been 
identi?ed as a putative APP ligand (Williamson et al., 1996). APP may also be 
important for interactions between the cell surface and the extracellular matrix, 
since the extracellular matrix protein F-spondin also binds to the APP extracellular 
domain (Ho and Sudhof, 2004). The most C-terminus heparin-binding contains 
the 676RHDS679 (APP770 numbering) sequence, which is an integrin-binding motif 
(Ghiso et al., 1992). 
The extracellular domain of APP also contains binding-sites for metals such 
as zinc and copper (Fig. I.4) (Maynard et al., 2005). Zn(II)-binding is assumed to 
play a structural role, whereas APP was shown to catalyse the reduction of Cu(II) 
to Cu(I) (Bush et al., 1994; Multhaup et al., 1994). 
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Figure I.4: Structure of APP showing some of the major functional domains. TM: 
transmembrane domain; Binding domains: Heparin (Hp), Copper, Zinc, Collagen 
(Col), G0 proteins (G).  
 
 
APP as an integral membrane protein 
 
Given the APP structure as a type I integral membrane protein, which 
resembles a membrane-anchored receptor molecule, several studies 
demonstrated that full-length APP could function as a cell surface G-protein-
coupled receptor (Okamoto et al., 1995). Despite being controversial, these 
results demonstrate that APP binds to heterotrimeric G proteins (G0), involved in 
signal transduction. However, a ligand for the putative APP receptor has not yet 
been identified, although fibrillar forms of Abeta were reported to bind to cell-
surface APP (Lorenzo et al., 2000). 
Moreover, it is suggested that the APP protein family has a role in the 
Reelin signalling pathway, and may participate in neuronal migration and 
positioning during brain development (Wirths et al., 2001). The regulation of APP 
by cholinergic mechanisms suggests that the molecule might be multifunctional 
and play different roles in development and ageing (Bayer et al., 2001). 
The receptor-like architecture of APP, with a conserved cytoplasmic 
domain, and cell-surface localization, prompted theories that addressed the 
processing by RIP (Regulated Intramembrane Proteolysis) (Koo, 2002; von Rotz 
et al., 2004). These molecules have a peptide sequence within their protein 
structure that is released after two consecutive cleavages on the protein (RIP 
The use of YTH to support the Notch-like signalling of APP CHAPTER I 
Centro de Biologia Celular      27 
Universidade de Aveiro 
proteolysis), and can be targeted to the nucleus where it activates gene 
expression (Schroeter et al., 2003).  
The thrilling discovery that both Notch and APP are processed by RIP led to 
potential implications in the basic mechanisms of brain development and 
degeneration. Notch is a type I transmembrane receptor involved in cell fate 
decisions during embryogenesis and functions through cellular RIP. Upon ligand 
binding, Notch is proteolytically processed, initially by a TACE- or by ADAM10, 
followed by ?-secretase intramembrane cleavage (De Strooper et al., 1999). In 
these respects APP and Notch processing may be similar (Selkoe and Kopan, 
2003). In addition, the subsequent ?-secretase cleavage occurs at a site (?-site) 
corresponding to the S3 cleavage of Notch (Sastre et al., 2001). Both the Notch 
Intracellular Domain (NICD), and the APP intracellular domain (AICD) can act as a 
transcription factor (Cao and Sudhof, 2001; Cupers et al., 2001). The AICD 
fragment is extremely small when compared with the NICD and lacks motifs 
commonly found in transcriptional regulators, suggesting that it may function in 
signalling in a different way, specifically by interaction with adaptor proteins, 
activating transcription by an indirect mechanism (Cao and Sudhof, 2004). 
Significant to AD is the aspect that RIP signalling can increase gene expression. 
Therefore, in order to contribute to our understanding of molecular basis of AD it 
is important to investigate the pathways of AICD nuclear targeting and its 
involvement in gene transcription. Thus, it is fundamental to identify the AICD 
binding proteins, which are determinant for specifying protein function. 
 
 
Functions of sAPP 
 
The secreted APP fragments have been shown to be involved in neuronal 
cell survival, adhesive interactions, neurite outgrowth, synaptogenesis, and 
synaptic plasticity (Furukawa et al., 1996; Turner et al., 2003). sAPP effects on ion 
fluxes and various signalling pathways might underlie its reported physiological 
roles (Mattson, 1997). sAPP?  also induces activation of NF-?B and alter various 
The use of YTH to support the Notch-like signalling of APP CHAPTER I 
28    Centro de Biologia Celular 
Universidade de Aveiro 
second messengers and effectors including cyclic GMP and protein kinase G 
(Barger et al., 1995), phospholipase C/protein kinase C, extracellular signal-
regulated protein kinase (ERK) and inositol tri-phosphate (Greenberg et al., 1994; 
Greenberg et al., 1995).  
Secreted APP (sAPP) containing the KPI domain (57 aa stretch with 
homologies to the Kunitz-type protease inhibitors) was initially found to be 
identical to protease nexin II, a growth regulatory molecule produced by 
fibroblasts that is an inhibitor of extracellular serine proteinases (Schilling et al., 
1991; Hook et al., 1999). A growth-promoting effect of sAPP has been shown for 
fibroblasts and cultured neurons, and this activity was attributed to the 
403RERMS407 sequence (APP770 numbering), which is within the heparin-binding 
domain (Fig. I.4) (Ninomiya et al., 1994). Secreted APP has also been reported to 
be neuroprotective and sAPP is capable of protecting cells against Abeta or 
glutamate-mediated neuronal damage (Furukawa et al., 1996). The sAPP?  
fragment was reported to be 100-fold more effective than sAPP?  in protecting 
hippocampal neurons against Abeta mediated toxicity. This may be due to the 
VHHQK heparin-binding domain (aa 12-16 of Abeta) which is present on sAPP?  
but not sAPP?  (Ohsawa et al., 1997). 
 
 
Functions of Abeta 
 
Biological activities of Abeta seem to be critically dependent on its state of 
aggregation, with its dimeric or oligomeric (protofibrilar) forms possessing 
cytotoxic properties (Roher et al., 2000; Walsh et al., 2000). Interestingly, the 
neurotoxic properties of injected Abeta on primate brains only appeared in aged 
but not in young animals, suggesting that aged brains may be more vulnerable to 
Abeta-mediated toxicity (Geula et al., 1998). However further complexity is added 
to the system being that weak neurotrophic properties were also attributed to the 
Abeta soluble form (Atwood et al., 2003). 
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Several studies demonstrated that Abeta affects neuronal signalling. For 
instance, physiological concentrations of Abeta increased tyrosine phosphorylation 
and phosphatidylinositol 3-kinase activity in cultured cortical neurons (Luo et al., 
1995). Abeta1-42 activated phospholipase A2 (PLA2) (Lehtonen et al., 1996) and 
Abeta1-40 maximally activated NF-?B (an immediate-early transcriptional 
regulator of numerous proinflamatory genes) in primary neurons (Kaltschmidt et 
al., 1997). Other studies report Abeta induced rapid changes in intracellular Ca2+ 
levels and ecto-PKC (Wolozin et al., 1995). 
 
 
I.3 THE CYTOPLASMIC DOMAIN OF APP 
 
The functions attributed to AICD are related either to its phosphorylation or 
to interactions with other proteins. The carboxy-terminus of APP contains three 
functional motifs corresponding to phosphorylation sites, critical for interaction 
with binding proteins that are thought to regulate the rate of APP secretion, 
endocytosis, and Abeta production (da Cruz e Silva et al., 2004). The 653YTSI656 
(APP695 isoform numbering) sequence matches YXXI tyrosine-based internalization 
and/or basolateral sorting signal. The second is the motif 667VTPEER672, containing 
the Thr-668, which is important for controlling interactions with APP binding 
proteins. The third domain 682YENPTY687, which is absolutely conserved across APP 
homologues and across species (Fig. I.5), contains a NPXY motif, which is found in 
several cell surface proteins, including growth factor receptors, transporters and 
adhesion molecule receptors. 
The NPXY sequence was first identified as the sequence required for 
internalization of LDL receptors. In some cases, NPXY motifs are required for 
anchoring of receptors in clathrin-coated pits (Chen et al., 1990). NPXY motifs are 
also important for the function of some molecules, e.g. in insulin-like growth 
factor receptors. The NPXY motif is required for efficient ligand-mediated 
internalization and biological signalling (Hsu et al., 1994). In the cytoplasmic tail 
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of integrin ?3 the NPXY sequence is essential for post-ligand-binding events 
involved in cell migration (Filardo et al., 1995). Furthermore, the NPXY motifs 
found in many integrin ?  subunits regulate the affinity for their ligands. 
Interestingly, an NPXY sequence in the integrin ? 1 cytoplasmic domain is required 
for localization to focal adhesions (Reszka et al., 1992), which in turn is necessary 
for integrins accurate functioning. In the EGF receptor, tyrosine phosphorylation 
of NPXY is required for recognition by Shc and subsequent signalling (Russo et al., 
2002).  
 
 
Figure I.5: The short cytoplasmic tail of APP and its homologues contains the YENPTY 
sequence, which is phylogenetically conserved. 
 
 
The YENPTY sequence was also demonstrated to be important in the 
regulation of APP processing and trafficking (Lai et al., 1995)). APP deletions 
within the YENPTY sequence results in increased secretion of sAPP and decreased 
secretion of A?  (Koo and Squazzo, 1994). The effects of these deletions are 
thought to be the result of altered internalization of APP from the cell surface. 
Mutation of the second tyrosine in the YENPTY sequence to alanine also increases 
sAPP secretion but has no effect on A?  secretion (Jacobsen et al., 1994), 
suggesting that secretion of A?  and sAPP may be regulated independently by 
signals in the cytoplasmic tail of APP. These observations bring together the AICD 
YENPTY-dependent regulation and the AICD role in AD.  
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I.4 AICD-BINDING PROTEINS 
 
Given the characteristics of the APP cytoplasmic tail, the complex network 
of protein-protein interactions that centred around it became an exciting new 
target for therapeutic intervention (Russo et al., 1998; Annaert and De Strooper, 
2002). Many proteins, indeed, interact with this C-terminal domain of APP, most 
of them possessing multiple protein-protein interacting domains, which in turn 
form complexes with other proteins. This suggests that these proteins function as 
adaptor proteins bridging APP to specific molecular pathways. 
Several laboratories have used the AICD as ‘‘bait’’ in the yeast hybrid 
systems, identifying two major families of APP binding proteins, the FE65 proteins 
and the X11/Mint proteins (Fiore et al., 1995; Bressler et al., 1996; Guenette et 
al., 1996; McLoughlin and Miller, 1996; Borg et al., 1998b; Lau et al., 2000a; Lau 
et al., 2000b; Mueller et al., 2000; Minopoli et al., 2001; Zambrano et al., 2001).  
Examples of APP binding proteins involved in signal transduction are: Abl, 
Disabled-1 protein (mDab-1), Fe65 and Fe65-like proteins, X11 (or MINT-1) and 
X11-like proteins (or MINT-2 and 3), Numb, G0 and the UV-damaged DNA-binding 
protein (Fig.I.6) (Turner et al., 2003). 
Several APP binding proteins are involved in APP subcellular localization 
including PAT1, Kinesin and JNK/JIP-1 (Jun N-terminal kinase (JNK) interacting 
protein 1) and the X11/MINT family proteins (Fig.I.6), the latter with a role in 
microtubule association, and recently found putative functions as an APP vesicle 
coat-protein (Okamoto and Sudhof, 1997; da Cruz e Silva et al., 2004). The 
already mentioned binding to G0, which links APP to G-protein signalling, is likely 
to play a role in APP targeting, since G0 and other related heterotrimeric G-
proteins were found to be located at subcellular membranes domains that are 
specialized in the sorting of trafficking proteins (Turner et al., 2003). The function 
of all the APP binding proteins has yet to be completely elucidated, but 
considerable contributions have already been made.  
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Figure I.6: Protein network around the cytoplasmic domain of APP (adapted from 
(Turner et al., 2003)). 
 
 
FE65 protein family 
 
FE65 is a multimodular adaptor protein, possessing three protein-protein 
interacting domains: a WW domain (a protein module with two conserved 
triptophans) and two tandem phosphotyrosine binding domains – PTB1 and PTB2 
(or phosphotyrosine interaction domains – PID1 and PID2) (Bressler et al., 1996; 
McLoughlin and Miller, 1996). The Fe65 family comprises three members: FE65, 
FE65L1 and FE65L2, being all reported to interact with APP (Fiore et al., 1995). 
Whereas, the FE65L1 and FE65L2 are ubiquitously expressed the FE65 is 
neuronally enriched and a splice variant of FE65 (E9) is neuronal specific (Fiore et 
al., 1995; Duilio et al., 1998).  
The most extreme C-terminal phosphotyrosine binding domain (PTB2) of 
FE65 is responsible for the interaction with the Alzheimer’s Amyloid Precursor 
Protein (APP) intracellular domain, through the latter’s YENPTY motif. The 
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pathways for APP processing are particularly important with respect to the 
generation of the Abeta peptide, which is deposited in the Alzheimer’s disease 
(AD) brain. The amyloidogenic processing, with the subsequent Abeta production 
is affected by the interaction of APP with FE65 (Sabo et al., 1999). Likewise FE65 
also appears to bind to APP like proteins (APLP1 and APLP2) (Duilio et al., 1998). 
Interaction of the FE65 PTB2 domain with APP requires the YENPTY motif 
as well as Thr-668, 14 residues N-terminal to the internalization sequence. 
Phosphorylation of APP Thr-668 impairs FE65 interaction suggesting that adaptor 
protein interactions with APP are differentially regulated by phosphorylation 
states. APP has been demonstrated to act as a cytosolic anchor for FE65, able to 
regulate its nuclear translocation (Ando et al., 2001). 
Besides APP-binding, FE65 in turn forms complexes with other proteins, 
suggesting that it bridges APP to specific molecular pathways (Fig. I.7). For 
instance, FE65 has been found to be associated with Neurofibrillary Tangles 
(NFTs) in AD. The main constituent of NFTs is Tau, a protein involved in neurite 
morphogenesis, axonal growth and axonal transport (Shahani and Brandt, 2002; 
Stamer et al., 2002). In AD Tau is hyperphosphorylated, which favours expansion 
of NFTs. Barbato et al. demonstrated the interaction of FE65 PTB1 domain with N-
terminal domain of Tau in vivo and in vitro. The physical interaction between the 
adaptor protein FE65 and Tau is dependent on microtubule network integrity and 
is regulated by Tau phosphorylation, apparently via the proline-directed kinases 
GSK3ß and Cdk5, since they are reported to be complexed with phosphorylated 
Tau (Hamdane et al., 2003; Barbato et al., 2005). This interaction suggests that 
FE65 bridges Tau to APP, representing a functional link between the two 
hallmarks of AD, namely NFTs and amyloid plaques. 
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Figure I.7: FE65 contains multiple protein 
interaction domains: the PTB1 domain 
interacts with the transcription factor 
complex CP2/LSF/LBP1 and with LRP, 
linking FE65 to ? 2M and ApoE; the PTB2 
domain interacts with APP; the WW 
interacts with Mena, thus linking FE65 and 
APP to actin (adapted from (King and Scott 
Turner, 2004). 
 
 
The PTB1 domain of FE65 binds the low density lipoprotein receptor-
related protein (LRP), a transmembrane glycoprotein which mediates the 
internalization and degradation of extracellular ligands, including a-2-
macroglobulin, apolipoprotein E and KPI-containing isoforms of APP (Trommsdorff 
et al., 1998; Herz and Strickland, 2001). LRP interacts with APP also by an 
extracellular ligand-receptor interaction. FE65 in turn interacts with the 
cytoplasmic tails of APP and LRP, acting as a bridging protein. Pietrzik et al. 
demonstrated that FE65 can also be a functional linker between APP and LRP and 
the APP-FE65-LRP complex formation is critical for APP processing (Pietrzik et al., 
2004). 
The WW domain of FE65 binds proline-containing motifs (PPXY or PPLP) of 
Mena (mammalian homologue of enabled), a protein involved in the regulation of 
actin dynamics (Ermekova et al., 1997). Mena belongs to the Ena/VASP family of 
proteins, which concentrate in focal adhesions and stress fibers and are found in 
dynamic actin remodeling areas, e.g. lamellipodia and axonal growth cones 
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(Ermekova et al., 1997). FE65 and APP colocalize with Mena in lamellipodia, which 
associates the FE65-APP complex to cytoskeletal dynamics and cellular motility 
and morphology (Sabo et al., 2001). Integrins are concentrated in lamellipodial 
adhesion sites, where they co-localize with FE65 and APP. FE65 PTB1 binds the 
ß1-integrin cytoplasmic domain, at one of the two NPXY motifs of the latter. 
Integrins are a family of cell adhesion receptors that mediate cell–matrix 
interactions, playing a role in cell proliferation, differentiation, and migration 
(Sabo et al., 2001). Another ligand for FE65 WW domain is the c-Abl tyrosine 
kinase, which phosphorylates FE65 on Tyr-547, in the PTB2 domain. Tyrosine 
kinase c-Abl is localized within the nucleus and also phosphorylates APP, on Tyr-
682 (Zambrano et al., 1997; Zambrano et al., 2001; Perkinton et al., 2004). 
The FE65 N-terminal PTB1 domain binds the transcription factor 
CP2/LSF/LBP1, involved in the regulation of several genes. The FE65-
CP2/LSF/LBP1 complex was found both in nuclear and non-nuclear fractions 
(Zambrano et al., 1998); however the ternary complex AICD–FE65– 
CP2/LSF/LBP1 can assemble in the nucleus, inducing GSK-3ß expression which 
can potentially increase Tau phosphorylation, contributing to AD (Kim et al., 
2003). Other transcriptional factors may also be formed, for example the PTB1 
FE65 domain functionally interacts with the histone acetyltransferase Tip60, 
forming the complex AICD–FE65–Tip60 which may regulate gene transcription 
(Cao and Sudhof, 2001). Alternatively, APP may anchor FE65 in the cytoplasm 
impairing its nuclear translocation (Minopoli et al., 2001). 
 
 
X11/mint protein family 
 
The X11/mint protein family comprises three members: X11? , ? , and ? or 
mint-1, -2, and -3 or X11, X11-L and X11-L2 (McLoughlin and Miller, 1996; 
Tanahashi and Tabira, 1999a, 1999b). X11 family members contain divergent N-
terminal sequences but highly conserved C-termini consisting of a PTB domain 
and two PDZ domains. The “Mint” designation arose from interaction of X11 and 
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X11-L, but not X11-L2, with munc 18-1, a protein essential for synaptic vesicle 
docking and exocytosis (Biederer et al., 2002). While X11-L2 expression is 
ubiquitous, X11 and X11-L are expressed only in the brain (McLoughlin et al., 
1999; Hase et al., 2002). 
 
 
 
Figure I.8: X11 contains multiple protein 
interaction domains: the PTB domain 
interacts with the APP, the munc-
interacting domain (M) interacts with 
munc 18-1; the CASK-interacting domain 
(C) interacts with CASK-Veli complex. 
The two PDZ domain interact with 
several proteins (adapted from (King and 
Scott Turner, 2004). 
 
 
Besides binding to the YENPTY of APP, through its PTB domain, several 
other proteins have been reported to interact with X11 (Fig. I.8), for instance it 
interacts with CASK–Veli to form a heterotrimeric complex that may target 
transmembrane receptor proteins in polarized cells (Borg et al., 1998a). 
A yeast two-hybrid screen of a brain cDNA library using the X11 PTB 
domain as bait reveals a specific interaction with APP, APLP-1, and APLP-2 (Borg 
et al., 1996; McLoughlin and Miller, 1996; Tomita et al., 1999). In contrast, the 
PDZ domains of X11 may interact with several proteins (Fig. I.8) including 
presenilin-1 (Lau et al., 2000a), spinophilin–neurabin II, the copper chaperone of 
SOD1, the dendritic kinesin KIF-17 and, via X11-CASK-Veli,  to the N-methyl- -
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aspartate receptor NR2B subunit (King and Scott Turner, 2004). X11 was also 
reported to potentially interacting with itself by PDZ domain dimerization (Walhout 
et al., 2000). The X11/MINT protein family was implicated in APP vesicle coat-
protein (Okamoto and Sudhof, 1997; Hill et al., 2003). Several X11 binding 
proteins mediate synaptic functions, implying an adaptor role for X11 in the pre- 
and postsynaptic complex.  
 
 
I.5 PROTEIN PHOSPHORYLATION IN AD  
 
Protein phosphorylation is a major control mechanism of eukaryotic 
organisms, allowing for rapid and reversible regulation of multiple protein 
activities in response to diverse environmental and developmental changes. 
Protein phosphorylation is a reversible process in which a protein kinase transfers 
a phosphate group from ATP to a substract, altering the conformation and 
function of the latter. A protein phosphatase removes the phosphate and the 
protein reverts to its dephosphorylated state. The phosphorylation state of a 
single protein depends on the balance between the highly regulated cellular 
activities of multiple protein kinases and protein phosphatases. 
As knowledge on the molecular basis of AD expands, interest on protein 
phosphorylation continues to increase, as misregulation of normal 
phosphorylation/dephosphorylation control mechanisms is found to underlie an 
increasing number of pathologies. Since so many diseases have at their core a 
deficiency in cellular signalling involving protein phosphorylation, kinases have for 
some time been considered viable targets for the design of novel therapeutics, 
contrary to phosphatases, that only recently have started to be considered targets 
for the development of therapeutic strategies (da Cruz e Silva et al., 2004). 
Brain ageing is characterized by a progressive decline in cognitive functions 
and memory loss. Protein phosphorylation may be one of the fundamental 
processes associated with memory and brain function, playing a role in the 
processing of neuronal signals and in the short-term or long-term modulation of 
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synaptic transmission. In neurodegenerative disorders such as AD there is 
evidence for abnormal regulation of protein phosphorylation, which appears to 
contribute to the disease condition (Wagey and Krieger, 1998).  
The high levels of protein kinases and phosphatases in the brain suggest 
that phosphorylation is critically important in brain function. Misregulation of the 
cellular phosphorylation system has been reported to occur in AD. These include 
abnormalities in both expression and activity levels of kinases, and/or 
phosphatases, thus leading to alterations in the processing of APP and Abeta 
production (Gandy et al., 1993; da Cruz e Silva et al., 1995). For instance, altered 
activities of protein kinase C (PKC), decreased activity of phosphatases PP1 and 
PP2A, overexpression of calcineurin mRNA levels, protein Tau and Beta-tubulin 
hyperphosphorylated state have all been associated with AD (Gong et al., 1993; 
Matsushima et al., 1996; Bennecib et al., 2000; Vijayan et al., 2001; da Cruz e 
Silva and da Cruz e Silva, 2003). Concomitantly, many proteins that are relevant 
to AD, including APP, Tau, PS-1 and PS-2, or BACE, are phosphoproteins. It is also 
worth noting that alterations on the phosphorylation state of AICD were recently 
reported in the brains of AD patients (Lee et al., 2003). 
 
 
 
Figure I.9: AICD phosphorylatable residues: Thr654, Ser655, Thr668 and 
Tyr682 and Tyr687. 
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AICD has five potentially phosphorylatable residues , which belong to three 
APP functional motifs previously mentioned in section I.3: 653YTSI656, 
667VTPEER672, and 682YENPTY687 (Fig. I.9).  
In the internalization signal domain 682YENPTY687, Tyr682 phosphorylation is a 
consensual site, in contrast with Tyr687 phosphorylation (Haass et al, 1993; Koo et 
al 1994; Minopoli et al, 2001). However Tyr687, which is within the consensus 
sequence “NPTY”, was recently reported to be phosphorylated in vivo (Lee et al., 
2003), concomitantly with results from our group (unpublished). 
 
 
I.6 AIMS OF THE THESIS 
 
In AD, phosphorylation/dephosphorylation of consensus sites in the 
intracellular domain of APP is believed to affect its subcellular localization and 
subsequent APP metabolism and Abeta production, probably through regulating 
the interactions with other proteins. We known from work in the laboratory (S. 
Rebelo et al, personal communication), that tyrosine-687 phosphorylation 
specifically affects subcellular localization of APP. The identification of neuronal 
specific binding proteins will contribute to elucidate some of the biochemical 
mechanisms controlling AICD function, specifically from a signal transduction 
perspective. Furthermore human AICD binding proteins represent potential targets 
for novel therapeutic approaches in AD. 
The use of Yeast Two-Hybrid method for the identification of interacting 
proteins allows for the selection, among a large number of clones, from a human 
brain cDNA library, of proteins capable of interacting with a bait protein. Therefore 
the aim of this work was to identify brain proteins capable of interacting with the 
APP intracellular domain harbouring a mutation that mimics the phosphorylation 
state of tyrosine-687. To achieve this a YTH screen was carried out using as bait 
the AICDY687E. Therefore, the specific aims were as follows: 
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1. Construct the bait plasmid with AICDY687E cDNA in PAS2-1 vector, in frame 
with GAL4-BD, and transform it into Y187 yeast strain.  
 
2. Verify the expression of the fusion protein GAL4-BD/AICDY687E by 
immunoblotting. 
 
3. Perform the Two-Hybrid Screen using large-scale yeast mating with a 
pretransformed brain library. 
 
4. Identify the positive clones. 
 
5. Confirm the interactions between selected positive clones and AICDY687E, 
and also with the counterpart peptides, wild-type AICD and AICDY687F 
(also inserted in pAS2-1 vector). 
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II YEAST-TWO HYBRID SCREEN 
 
 
II.1 INTRODUCTION 
 
In order to find new interactions between APP and other proteins a screen 
using the MATCHMAKER GAL4 Two-Hybrid System was carried out for a human 
brain library obtained from Clontech. Several steps were required to prepare the 
YTH screen, namely, bait plasmid construction and transformation into Y187 yeast 
strain. The transformants were assayed for HIS3, ADE2 and MEL1 reporter genes’ 
activation and the bait protein expression was verified by immunoblotting, 
following preparation of the yeast protein extracts. The YTH screen was then 
performed by yeast mating. 
The vector used to insert the bait cDNA encoding AICDY687E, was Clontech’s 
GAL4 binding domain expression vector pAS2-1 (Appendix IV). pAS2-1 has several 
characteristics that make it suitable for YTH. It has the GAL4-BD, two independent 
yeast and bacteria replication origins, it confers ampicillin and cycloheximide 
resistance and allows the yeast to grow without tryptophan in the culture media. 
It also has a multiple cloning site which used to insert the bait cDNA. 
The cDNA for human AICDY687E was amplified by PCR from a vector in the 
laboratory containing this APP mutant cDNA (pAV10). 
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II.2 CONSTRUCTION OF THE BAIT PLASMID 
 
II.2.1  Materials and Methods 
 
For the complete composition of all reagents, media and solutions used, see 
Appendix I. All the reagents were cell culture grade or ultrapure. 
 
 
II.2.1.1  Isolation of pAS2-1 plasmid from bacteria - 
PROMEGA “Megaprep” 
 
A 1L cell culture was pelleted by centrifugation at 1,500g for 20 min at RT. 
The cell pellet was resuspended in 30ml of Cell Resuspension Solution by manually 
disrupting the pellet with a pipette. 30ml of Cell Lysis Solution were added to the 
cells and the solution mixed gently by inverting until it became clear and viscous. 
Then, 30ml of Neutralization Solution were added and immediately mixed by 
inverting the tube. After centrifugation at 14,000g for 15 min at RT the clear 
supernatant was transferred by filtering through gauze swabs to a new tube and 
the volume of supernatant was measured. At this stage 0.5 volumes of RT 
isopropanol were added and the solution mixed by inversion. This solution was 
centrifuged at 14,000g for 15 min at RT, the supernatant was discarded and the 
pellet resuspended in 4ml of TE buffer. 20ml of WizardTM Megapreps DNA 
purification resin were added to the DNA and mixed by swirling. A Wizard TM 
Megacolumn was inserted into the vacuum manifold port and the DNA/resin mix 
was transferred into the Megacolumn. Vacuum was applied to pull the mix through 
the Megacolumn. Two washes with 25ml of Column Wash Solution were 
performed and the resin was rinsed with 10ml of 80% ethanol. The Megacolumn 
was inserted into a 50ml screw cap tube and centrifuged at 2,500 rpm for 5 min 
using a swinging bucket rotor centrifuge. The Megacolumn was placed in a clean 
tube and 3ml of pre-heated nuclease-free water (70ºC) were added to the 
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column. After waiting 1 min the DNA was eluted by centrifugation at 2,500 rpm for 
5 min. The DNA was stored at –20ºC. 
This procedure was used to prepare large amount of plasmid DNA for 
storage and subsequent cloning, yeast transformation and other purposes.  
 
 
II.2.1.2 Plasmid DNA digestion with restriction enzymes 
 
Plasmid DNA was sequentially digested with Sma I and Nco I with the DNA 
being precipitated between the digests. 
For a typical DNA digestion the manufacturer’s instructions were followed. 
In a microtube the following components were added: 
? 100µg/ml DNA 
? 1X reaction buffer (specific for each restriction enzyme)  
? 1U/µg DNA of restriction enzyme 
The mixture was incubated at the appropriate temperature (30ºC for Sma I; 
37ºC for Nco I) for a few hours (or overnight if convenient). 
 
 
II.2.1.3  Plasmid DNA purification with ethanol 
 
 This method was used to concentrate nucleic acids as well as to 
purify them. Approximately 1/10 volume of 3M sodium acetate (pH 5.2) was 
added to the DNA solution to adjust the salt concentration, followed by 2 volumes 
of ice-cold ethanol. The solution was well mixed and stored at –20ºC for 30 min to 
allow the DNA precipitate to form. DNA was recovered by centrifugation at 4ºC for 
15 min at 14,000 rpm. The supernatant was carefully removed without disturbing 
the pellet. The microtube was half filled with ice-cold 70% ethanol and 
recentrifuged at 14,000 rpm for 5 min. The supernatant was again removed and 
the pellet allowed to dry before being resuspended in sterile water.  
The use of YTH to support the Notch-like signalling of APP CHAPTER II 
44    Centro de Biologia Celular 
Universidade de Aveiro 
II.2.1.4 AICDY687E cDNA amplification by PCR 
 
The gene fragment was generated by PCR with the Nco I and Sma I 
restriction sites incorporated into the primers NAAPC and APPCTERMIII, 
respectively. The reaction was carried out in a 0.5ml tube where the following 
components were added: 
? 10ng template DNA 
? 10pmol NAPPC primer 
? 10pmol APPCTERMIII primer 
? 2µl dNTP’s 10mM 
? 1x reaction Taq buffer  
? 2 Units of Taq  
? H2O to a final volume of 50µl 
 
The PCR was then performed using the following conditions: 
95ºC 4 min 
 95ºC 30 sec 
 55ºC 30 sec               5 cycles 
 72ºC 1 min 
 95ºC 30 sec 
 60ºC 30 sec               25 cycles 
 72ºC 1 min 
 
 
II.2.1.5 Insert digestion with restriction enzymes 
 
The PCR product was sequentially digested with Sma I and Nco I, with a 
purification step between the two reactions, as described in sections II.2.1.2 and 
II.2.1.3. 
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II.2.1.6  Insert DNA purification – QIAGEN DNA Purification 
kit 
 
The QIAGEN DNA Purification kit was used to purify DNA fragments from PCR 
and other enzymatic reactions. It allowed purification from primers, nucleotides, 
polymerases and salts by using QIAquick spin columns. Briefly, 5 volumes of 
buffer PB were added to 1 volume of the solution to be purified and mixed. The 
spin column was placed in a collection microtube and the sample was applied to 
the column and centrifuged for 1 min at 14,000 rpm to bind the DNA. The flow-
through was discarded and the column was washed with 0.75ml of buffer PE, 
centrifuged for 1 min at 14,000 rpm and the flow-through discarded. The column 
was placed back in the same microtube and centrifuged again to remove traces of 
washing buffer. Then, the column was placed in a clean microtube, 50µl of H2O 
were added and allowed to stand for 1 min. To elute the DNA, the column was 
centrifuged for 1 min at 14,000 rpm. 
 
 
II.2.1.7 DNA ligation 
 
Alkaline phosphatase treatment 
In order to prevent self ligation of vector molecules, the digested plasmid 
DNA was incubated with shrimp alkaline phosphatase (SAP) (ROCHE) before 
ligation. According to the manufacturer’s instructions, the reaction mixture was 
adjusted with 1/10 volume 10X concentrated dephosphorylation buffer, and 
incubated with 1µl of SAP at 37ºC for 1 hr. Finally, SAP was inactivated by heating 
the reaction mixture at 65ºC for 15 min. 
 
DNA Ligation 
To carry out the ligation reaction, 50ng of vector DNA were transferred to a 
microtube with three times the equimolar amount of insert DNA. 2µl of 10X 
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bacteriophage T4 DNA ligase (PROMEGA) buffer and 1µl of bacteriophage T4 DNA 
ligase were added to the reaction mix and H2O was added to a final volume of 
20µl. The reaction was carried out for 16 hr at 16ºC. One additional control 
reaction was set up that contained the plasmid vector alone.  
 
 
II.2.1.8  Bacteria transformation with plasmid DNA 
 
Preparation of E. coli competent cells 
A single colony of E. coli XL1-Blue was incubated in 10ml of SOB medium at 
37ºC overnight. Then, 1ml of this culture was used to inoculate 50ml of SOB and 
the culture was incubated at 37ºC with shaking 220 rpm for 1-2 hr, until 
OD550nm=0.3. The culture was cooled on ice for 15 min and centrifuged at 4,000 
rpm at 4ºC for 5 min. The supernatant was discarded and then resuspended in 
15ml of Solution I. After standing on ice for 15 min, the cells were centrifuged at 
4,000 rpm for 5 min at 4ºC and 3ml of Solution II were added to  resuspend the 
cell pellet. The cells were immediately divided in 100µl aliquots and stored at -
80ºC. 
 
Bacteria transformation with plasmid DNA 
Competent cells (100 µl) were thawed on ice and 0.1-50ng of DNA were 
added to the cells and gently swirled. The microtube was incubated on ice for 20 
min and heat shocked at 42ºC for 90 sec. The microtubes were then incubated on 
ice for 30 min before adding 0.9ml of SOC medium. The tubes were subsequently 
incubated at 37ºC for 30 min with shaking at 220 rpm. The culture was 
centrifuged at 14,000 rpm and the supernatant discarded. The cells were then 
resuspended in 100µl of the selective medium and spread on the appropriate agar 
medium. The plates were incubated at 37ºC for 16 hr until colonies appeared. 
Control transformations were also performed in parallel. These always included a 
negative control transformation without DNA and a positive control transformation 
with 0.1ng of a control plasmid, such as pAS2-1.  
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II.2.1.9  Isolation of plasmids from transformants “Miniprep” 
 
In order to screen for the recombinant plasmid in the transformants, the 
plasmid DNA was extracted from several isolated bacterial colonies for subsequent 
restriction fragment analysis and sequencing. 
 
Method 1 – Alkaline lysis “mini-prep” 
 A single bacterial colony was transferred into 3ml of LB medium containing 
ampicillin (100µg/ml) and incubated overnight at 37ºC with vigorous shaking 
(220-250 rpm). 1.5ml of this culture were transferred into a microtube and 
centrifuged at 14,000 rpm for 1 min at 4ºC and the supernatant was discarded. 
The cell pellet was resuspended in 100µl of ice-cold solution I by vigorous 
vortexing. Then, 200µl of freshly prepared solution II were added to the 
microtube that was mixed by inverting several times. Keeping the microtube on 
ice, 150µl of ice-cold solution III were added and again the microtube inverted 
several times. After the microtube was allowed to stand on ice for 5 min, it was 
centrifuged at 14,000 rpm for 10 min at 4ºC and the supernatant transferred to a 
clean microtube. The DNA was precipitated by adding 2 volumes of ice-cold 
ethanol. The mixture was vortexed and placed at -20ºC for 30 min. After 
centrifugation at 14,000 rpm for 10 min at 4ºC, the supernatant was completely 
removed and the pellet washed with 70% ethanol. Following centrifugation, the 
pellet was allowed to air-dry for 10 min. The DNA was dissolved in H2O containing 
DNAase-free pancreatic RNAase (20µg/ml) and stored at -20ºC. 
 
Method 2 – QIAGEN “miniprep” 
 The bacterial pellet was obtained as described above. The pellet was then 
resuspended in 250µl of buffer P1, 250µl of buffer P2 were added and the 
microtube was mixed by gently inverting until the solution became viscous and 
slightly clear. Afterwards, 350µl of buffer N3 were added and the microtube was 
repeatedly inverted until the solution became cloudy. The microtube was 
centrifuged for 10 min and the resulting supernatant was applied to a QIAprep 
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spin column placed in a microtube. After a 1 min centrifugation the flow-through 
was discarded. The column was washed by adding 0.75ml of buffer PE and 
centrifuged for 1 min to discard the flow-through, and then a subsequent 1 min 
centrifugation to remove residual wash buffer. Finally, the column was placed in a 
clean microtube and 50µl of H2O were added to elute the DNA by centrifuging for 
1 min having let it stand for 1 min. This method gives a cleaner DNA preparation 
than Method 1 with better yields. This method was used when the DNA was 
subsequently processed for DNA sequencing. For enzymatic restriction the first 
method was commonly employed. 
 
 
II.2.1.10 Restriction fragment analysis of DNA 
 
Plasmid DNA was analysed throughout the digestion with a convenient 
restriction endonuclease, namelly Hind III. For the plasmid DNA digestion the 
manufacturer’s instructions were followed. In a microtube the following 
components were added: 
? 100 µg/ml DNA 
? 1X reaction buffer (specific for each restriction enzyme)  
? 1U/µg DNA of restriction enzyme 
The mixture was incubated at the appropriate temperature (37ºC for Hind 
III) for a few hours. 
 
 
II.2.1.11 Electrophoretic analysis of DNA 
 
The electrophoresis apparatus was prepared and the electrophoresis tank 
was filled with enough 1X TAE to cover the agarose gel. The appropriate amount 
of agarose was transferred to an Erlenmeyer with 50ml 1X TAE. The slurry was 
heated until the agarose was dissolved and allowed to cool to 60ºC before adding 
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ethidium bromide to a final concentration of 0.5µg/ml. The agarose solution was 
poured into the mold and the comb was positioned. After the gel became solid the 
comb was carefully removed and the gel mounted in the tank. The DNA samples 
were mixed with the 6X loading buffer (LB) (0.25% bromophenol blue/ 30% 
glycerol in water) and the mixture was loaded into the slots of the submerged gel 
using a micropipette. Marker DNA (1kb ladder or ?-Hind III fragments) of known 
size was also loaded into the gel. The lid of the gel tank was closed and the 
electrical leads were attached so that the DNA migrated towards the anode. The 
gel was run until the bromophenol blue had migrated the appropriate distance 
through the gel. At the end, the gel was examined by UV light and photographed 
or analysed on a Molecular Imager (Biorad).   
 
 
II.2.1.12 DNA sequencing 
 
All the DNA samples to be sequenced followed the same protocol. If the 
DNA was obtained by the “alkaline lysis miniprep” method and had not been 
purified by QIAGEN miniprep spin column (section II.2.1.9), it was purified in a 
QIAquick spin column (QIAGEN DNA Purification Kit) as described bellow. 
 
QIAGEN DNA Purification kit 
Briefly, 5 volumes of buffer PB were added to 1 volume of the solution to 
be purified and mixed. The QIAquick spin column was placed in a collection 
microtube and the sample was applied to the column and centrifuged for 1 min at 
14,000 rpm to bind the DNA. The flow-through was discarded and the column was 
washed with 0.75ml of buffer PE, centrifuged for 1 min at 14,000 rpm and the 
flow-through discarded. The column was placed back in the same microtube and 
centrifuged again to remove traces of washing buffer. Then, the column was 
placed in a clean microtube, 50ml of H2O were added and allowed to stand for 1 
min. To elute the DNA the column was centrifuged for 1 min at 14,000 rpm. The 
DNA was stored at -20ºC. 
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Sequencing PCR reaction 
In a 0.5ml microtube the following components were added: 
? 500ng dsDNA  
? 4µl of Ready Reaction Mix* 
? 3.2pmol primer 
? H2O to a final volume of 20µl 
* Ready Reaction Mix is composed of: dye terminators, deoxynucleoside 
triphosphates, AmpliTaq DNA polymerase, FS, rTth pyrophosphatase, magnesium 
chloride and buffer (Applied Biosystems). 
This reaction mixture was vortexed and spun down for a few seconds. The PCR 
was then performed using the following conditions: 
 96ºC 1 min 
96ºC 30 sec 
 42ºC 15 sec               25 cycles 
 60ºC 4 min 
Afterwards, the samples were purified by ethanol precipitation (see above). 
Briefly, 2.0µl of 3 M sodium acetate (pH 4.6) and 50µl of 100% ethanol were 
added to the reaction microtube. The microtube was vortexed and incubated at 
RT for 15 min to precipitate the extension products. The microtube was then 
centrifuged at 14,000 rpm for 20 min at RT. After discarding the supernatant 
250µl of 70% ethanol were added, the microtube was briefly vortexed and 
recentrifuged for 5 min at 14,000 rpm at RT. The supernatant was discarded and 
the pellet dried. After this procedure the DNA was ready to be applied in an 
Automated DNA Sequencer (ABIPRISM 310, Applied Biosystems). 
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II.2.2  Results 
 
The resulting plasmid, named pAS-CYE, was sequenced to check the 
orientation of the AICDY687E and validate the reading frame of the fusion protein 
(Fig. II.1). 
 
 
 
Figure II.1: Partial sequence of the pAS-CYE construct. Human AICDY687E sequence is in 
blue; pAS2-1 sequence that is fused to AICD is in black; mutation site in Tyr-687 is in red; 
Nco I restriction site is in green and Sma I is in grey; Stop codon is in pink. 
 
 
atgaagctactgtcttctatcgaacaagcatgcgatatttgccgacttaaaaagctcaag 
M  K  L  L  S  S  I  E  Q  A  C  D  I  C  R  L  K  K  L  K 
 
tgctccaaagaaaaaccgaagtgcgccaagtgtctgaagaacaactgggagtgtcgctac 
C  S  K  E  K  P  K  C  A  K  C  L  K  N  N  W  E  C  R  Y 
 
tctcccaaaaccaaaaggtctccgctgactagggcacatctgacagaagtggaatcaagg 
S  P  K  T  K  R  S  P  L  T  R  A  H  L  T  E  V  E  S  R 
 
ctagaaagactggaacagctatttctactgatttttcctcgagaagaccttgacatgatt 
L  E  R  L  E  Q  L  F  L  L  I  F  P  R  E  D  L  D  M  I 
 
ttgaaaatggattctttacaggatataaaagcattgttaacaggattatttgtacaagat 
L  K  M  D  S  L  Q  D  I  K  A  L  L  T  G  L  F  V  Q  D 
 
aatgtgaataaagatgccgtcacagatagattggcttcagtggagactgatatgcctcta 
N  V  N  K  D  A  V  T  D  R  L  A  S  V  E  T  D  M  P  L 
 
acattgagacagcatagaataagtgcgacatcatcatcggaagagagtagtaacaaaggt 
T  L  R  Q  H  R  I  S  A  T  S  S  S  E  E  S  S  N  K  G 
 
caaagacagttgactgtatcgccggtattgcaatacccagctttgactcatatggccatg 
Q  R  Q  L  T  V  S  P  V  L  Q  Y  P  A  L  T  H  M  A  M 
 
gtgatgctgaagaagaaacagtacacatccattcatcatggtgtggtggaggttgacgcc 
V  M  L  K  K  K  Q  Y  T  S  I  H  H  G  V  V  E  V  D  A 
 
gctgtcaccccagaggagcgccacctgtccaagatgcagcagaacggctacgaaaatcca 
A  V  T  P  E  E  R  H  L  S  K  M  Q  Q  N  G  Y  E  N  P 
 
accgagaagttctttgagcagatgcagaactgacccggg 
T  E  K  F  F  E  Q  M  Q  N  ^^^ 
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II.3  EXPRESSION OF THE BAIT PROTEIN IN YEAST 
 
In order to verify the ability of the recombinant constructs to drive 
AICDY687E expression, they were transformed into the yeast strain Y187. The 
transformed cells were grown on the appropriate media and AICDY687E expression 
was confirmed by immunobloting of the corresponding protein extracts. The fusion 
protein GAL4-BD/AICDY687E was detected with the 369 antibody (that recognizes 
AICD), and an anti-rabbit secondary antibody conjugated to peroxidase. Detection 
of the GAL4-BD/AICDY687E fusion protein was also carried out with the GAL4 DNA-
BD antibody (Clontech) that recognizes the GAL4-BD. A protein extract from Y187 
transformed with pAS2-1 plasmid was used as a positive control, and as a 
negative control the protein extract from untransformed Y187 yeast cells was 
used.  
 
 
II.3.1  Materials and Methods 
 
II.3.1.1 Yeast transformation with plasmid DNA  
 
Preparation of competent yeast cells 
One yeast colony was inoculated into 1ml of YPD medium in a 1.5ml 
microtube and vortexed vigorously to disperse cell clumps. The culture was 
transferred into a 250ml flask containing 50ml of YPD and incubated at 30ºC with 
shaking at 230 rpm overnight, until it reached stationary phase with OD600nm>1. 
Enough of this culture (20-40ml) was transferred into 300ml YPD in a 2L flask to 
produce an OD600nm=0.2-0.3. The culture was incubated for 3 hr at 30ºC with 
shaking at 230 rpm, centrifuged at 2,200 rpm for 5 min at room temperature and 
the supernatant was discarded and the cells resuspended in 25ml H2O. The cells 
were recentrifuged and the pellet was resuspended in 1.5ml of freshly prepared, 
sterile 1X TE/LiAc.  
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Yeast transformation- Lithium acetate (LiAc)-mediated method 
In a microtube 200ng of plasmid DNA were added to 100µg of herring 
testes carrier DNA. Then, 100µl of freshly prepared competent cells were added to 
the microtube, followed by 600µl of sterile PEG/LiAc (40% PEG 4000/ 1X TE/ 1X 
LiAc). The solution was incubated at 30ºC for 30 min with shaking (200 rpm). 
After adding 70µl of DMSO the solution was mixed gently and then heat-shocked 
for 15 min in a 42ºC water bath. The cells were pelleted after being chilled on ice, 
centrifuged for 5 sec at 14,000 rpm and resuspended in 0.5ml of 1X TE buffer. 
The cells (100µl) were then plated in the appropriate SD selection medium (e.g. 
SD/-Trp both for the plasmids pAS2-1 and pAS-CYE), and incubated at 30ºC for 2-
4 days, until colonies appear. 
 
 
II.3.1.2 Expression of proteins in yeast  
 
Preparation of yeast cultures for protein extraction 
A colony of each previously transformed yeast was inoculated in 5ml of the 
appropriate SD selection medium and incubated at 30ºC with shaking at 230 rpm 
overnight. As a negative control an untransformed yeast colony was inoculated in 
YPD. The overnight cultures were vortexed and separately added to 50ml aliquots 
of YPD. These cultures were incubated at 30ºC with shaking (220 rpm) until 
OD600nm=0.4-0.6. At this point the cultures were quickly chilled by pouring them 
into a prechilled 50ml centrifuge microtube halfway filled with ice. The tubes were 
immediately centrifuged at 1,000g for 5 min at 4ºC. The supernatant was 
discarded and the cell pellet was washed in 50ml of ice-cold water. The pellet was 
recovered by centrifugation at 1,000g for 5 min at 4ºC and immediately frozen by 
placing tubes in liquid nitrogen.  
 
 
 
 
The use of YTH to support the Notch-like signalling of APP CHAPTER II 
54    Centro de Biologia Celular 
Universidade de Aveiro 
Preparation of protein extracts 
The cell pellets were quickly thawed by resuspending each one in 100µl of 
prewarmed cracking buffer (60ºC) per 7.5 OD600 units of cells (OD600 of a 1ml 
sample multiplied by the culture volume). The samples were briefly thawed in a 
60ºC water bath. After 15 min an additional aliquot (1µl of 100X PMSF per 100µl 
of cracking buffer) of the 100X PMSF stock solution was added to the samples and 
every 7 min thereafter during the procedure. Each cell suspension was transferred 
into a 1.5ml microtube containing 80 µl of glass beads per 7.5 OD600 units of cells. 
The samples were heated at 70ºC for 10 min to release the membrane-associated 
proteins. Then, the microtubes were vortexed vigorously for 1 min and centrifuged 
at 14,000 rpm for 5 min at 4ºC. The supernatants were transferred to fresh 
microtubes and placed on ice. The pellets were boiled for 5 min, vortexed for 1min 
and centrifuged again, being the resulting supernatants combined with the first 
ones. The samples were boiled and loaded immediately on a gel. 
 
 
II.3.1.3  SDS-PAGE  
In order to visualize the fusion protein GAL4-BD/AICDY687E, with molecular 
weight around 26 kDa, 12% gels were used (Table II.1). 
 
Table II.1: Composition of the running and stacking gels for SDS-PAGE. 
Components Running gel (12%) Stacking gel (3.5%) 
Water 10.35ml 6.60ml 
30%Acryl./8%Bisacryl.  12.00ml 1.20ml 
4X LGB 7.50ml ------- 
5X UGB ------- 2.00ml 
SDS 10% ------- 100.0µl 
10% APS 150.0µl 100.0µl 
TEMED 15.0µl 10.0µl 
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The 12% running gel was prepared by sequentially adding the components 
indicated on Table II.1 (APS and TEMED were added last, as they initiate the 
polymerising process). The solution was then carefully pipetted down the spacer 
into the gel sandwich, leaving some space (4 cm) for the stacking gel. Then, 
water was carefully added to cover the top of the gel and the gel was allowed to 
polymerise for 1 hr. The stacking gel was prepared according to Table II.1. The 
water was poured out and the stacking gel was added to the sandwich; a comb 
was inserted and the gel was allowed to polymerise for 30 min. Then, the samples 
were prepared by the addition of ¼? volume of loading gel buffer. The microtube 
was boiled and centrifuged, the combs removed and the wells filled with running 
buffer. The samples were carefully applied into the wells that were filled with 
running buffer, and the samples were run at 45mA until the bromophenol blue 
from the LB reached the bottom of the gel. 
 
 
II.3.1.4  Immunoblotting 
 
For immunoblotting the tank transfer system was used  as follows: 3MM 
blotter paper was cut to fit the transfer cassette and a nitrocellulose membrane of 
the gel size was also cut. The gel was removed from the electrophoresis device 
and the stacking gel removed and discarded. The transfer sandwich was 
assembled under transfer buffer to avoid trapping air bubbles. The cassette was 
placed in the transfer device filled with transfer buffer. Transfer was allowed to 
proceed overnight at 200mA. Afterwards, the transfer cassettes were 
disassembled; the membrane carefully removed and allowed to air dry prior to 
further manipulations.  
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II.3.1.5  Immunodetection by enhanced chemiluminescence 
(ECL)  
 
ECLTM is a light emitting non-radioactive method for the detection of 
immobilised antigens, conjugated directly or indirectly with horseradish 
peroxidase-labelled antibodies. In order to visualize the fusion protein GAL4 DNA-
BD/AICDY687E two distinct blots were probed with different antibodies: GAL4 DNA-
BD monoclonal antibody (Clontech) and 369 polyclonal antibody, that recognizes 
human AICD (a kind gift from Prof. Sam Gandy) 
 
 
GAL4 DNA-BD monoclonal antibody (Clontech)  
The membrane was soaked in 1X TBS for 10 min. Non-specific binding sites 
were blocked by immersing the membrane in 5% low fat milk in TBST for 2 hr. 
After washing with 1X TBST, the membrane was incubated with a solution of the 
primary antibody diluted in 5% low fat milk in TBST for 2 hr with shaking. After 
three washes of 10 min each in 1X TBST the membrane was incubated with a 
solution of the anti-mouse secondary antibody diluted (1:5000) in 5% low fat milk 
in TBST for 1 hr with shaking. The membrane was then washed 3 times for 10 
min. 
 
369 polyclonal antibody 
The procedure was similar with the described above, but the membrane was 
blocked by immersing it in 5% low fat milk in TBST for 3 hr, with shaking, plus an 
overnight incubation at 4ºC. After washing with 1X TBST, the membrane was 
incubated with a solution of the primary antibody diluted in 5% low fat milk in 
TBST for 2 hr with shaking. After washing 6 times for 15 min in 1X TBST the 
membrane was incubated with the anti-rabbit secondary antibody diluted (1:5000) 
in 5% low fat milk in TBST for 1:30 hr with shaking. The membrane was then 
washed 6 times for 15 min. 
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Subsequently the membrane was incubated for 1 min at RT with the ECL 
detection solution (a mixture of equal volumes of solution 1 and solution 2 from 
the ECL kit, approximately 0.125ml/cm2 membrane). Inside the dark room, the 
membrane was gently wrapped with cling-film, eliminating all air bubbles and 
placed in a film cassette and an autoradiography film (XAR-5 film, KODAK) was 
placed on the top. The cassette was closed and the blot exposed for short periods 
of time. The film was then removed and developed in a developing solution, 
washed in water and fixed in fixing solution. If needed, a second film was exposed 
more or less time according to the first result. 
 
 
II.3.2  Results 
 
The protein extracts produced in section II.3.1.2 were probed with GAL4 
DNA-BD monoclonal antibody, which recognised the GAL4 DNA-BD peptide (Fig. 
II.2, A).  
 
 
Figure II.2: Immunoblot analysis of yeast protein extracts, probed with GAL4-BD 
antibody (A), and with 369 antibody (B). Lane 1, control yeast transformed with pAS2-1 
vector; Lane 2 , pAS-CYE clones. The calculated molecular mass (in kDa) of the fusion 
proteins is  indicated. 
 
As expected for the control yeast, the peptide is smaller (21 KDa), because 
it’s encoded by pAS2-1 vector without the fusion construct. When probed with 369 
 
GAL4-BD (21 KDa)
GAL4 – AICD fusion (26 KDa)
2 21 1
A) B)
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antibody, in the first lane the GAL4 is not detected. A band of the expected 
molecular mass (26 KDa) was detected in the protein extract from yeast cells 
containing the pAS-CYE plasmid (Fig. II.2, B, lane 2), demonstrating that the yeast 
are expressing the fusion protein. 
The DNA-BD/Bait protein was tested for transcriptional activation. The bait 
constructs did not activate transcription from the UAS (the DNA sequence that is 
recognized by GAL4-BD) as detected by lack of growth of yeast cells containing 
the bait plasmid pAS-CYE on selective media SD/TDO/X-? -Gal and SD/QDO/ X-? -
Gal (data not shown). 
Once yeast cell expression of the fusion proteins GAL4-BD/AICDY687E was 
confirmed, the yeast two hybrid screen was performed. 
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II.4 TWO-HYBRID LIBRARY SCREENING USING YEAST MATING 
 
II.4.1  Methods 
 
II.4.1.1  cDNA library screening by yeast mating  
 
A concentrated overnight culture of the bait strain (Y187+pAS-CYE) was 
prepared by inoculating a colony of the bait strain into 50ml of SD/-Trp and 
incubating it at 30ºC overnight with shaking at 250 rpm. The next day, when 
OD600>0.8, the culture was centrifuged at 1,000g for 5 min, the supernatant was 
decanted and the pellet was resuspended in the residual liquid (5ml) by vortexing. 
The cells concentration (> 1X109 cells/ml) was verified in a haemocytometer. Just 
prior to use, a frozen aliquot (1ml) of the library culture (Pretransformed Human 
Brain MATCHMAKER cDNA Library) was thawed in a room temperature water 
bath. The library was gently mixed and 10µl were set aside for later tittering (see 
below). The entire bait strain culture was combined with the 1ml library aliquot in 
a 2L sterile flask, 45ml of 2X YPDA were added and gently swirled. This culture 
was incubated at 30ºC for 20-24 hr, with shaking at 40 rpm. After 20 hr of mating 
a drop of the mating culture was checked under a phase-contrast microscope to 
check for the presence of zygotes, thereafter allowing the mating to proceed for 
more 4 hr. The mating mixture was transferred to a sterile 50ml tube and the cells 
spun down at 1,000g for 10 min. The mating flask was rinsed twice with 2X YPDA 
(50ml) and the rinses were combined and used to resuspend the first pellet. The 
cells were centrifuged again at 1,000g for 10 min, the pellet resuspended in 10ml 
of 0.5X YPDA and the total volume (cells + medium) was measured. Half of the 
library mating mixture was plated on SD/QDO (SD without Leu, Trp, Ade and His), 
and the other half on SD/TDO (SD without Leu, Trp and His), at 200µl per 150mm 
plate. For mating efficiency controls, 100µl of 1:10,000, 1:1,000; 1:100 and 1:10 
dilutions of the mating mixture were plated in 100mm SD/-Leu, SD/-Trp and SD/-
Leu/-Trp plates. All plates were incubated at 30ºC until colonies appeared, 
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generally 3-8 days on TDO and 8-21 days on QDO medium. Then, growth of the 
control plates was scored and the mating efficiency and number of clones 
screened were calculated. All positive clones were replated twice in SD/QDO 
medium containing X-a-Gal and incubated at 30ºC for 3-8 days. True positives 
formed blue colonies. The master plates were sealed with parafilm and stored at 
4ºC. Glycerol stocks were prepared for all the positive clones. 
 
 
II.4.1.2 Library titering 
 
A library aliquot (10µl) was transferred to 1ml of YPDA in a 1.5ml microtube 
– dilution A (dilution factor 10-2). 10µl from dilution A were added to 1ml of YPDA 
in another microtube and mixed gently – dilution B (dilution factor 10-4). From 
dilution B, 100µl were spread onto three SD/-Leu plates. All the plates were 
incubated at 30ºC for 3 days after which the number of colonies was counted. The 
titer of the library was calculated using the following expression: 
?#colonies?/?plating volume (ml)x dil factor? = cfu/ml. 
 
 
II.4.2  Results 
 
II.4.2.1 Mating efficiency and number of clones screened 
 
After transforming the bait plasmids into the appropriate yeast strain, Y187 
(mat ? ), the next step was to obtain the desired library pretransformed in a yeast 
strain of the opposite mating type. In our case we used a pretransformed pACT-2 
library in the yeast strain AH109 (mat a) containing human brain cDNA sequences 
fused to the GAL4 activation domain (AD).  
The YTH screen was performed by yeast mating, whereby more unique 
positive clones are obtained, due primarily to the “jump-start” that the new 
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diploids receive before being plated on selective medium. Additionally, diploid 
yeast cells are more vigorous than haploid cells and can better tolerate the 
expression of toxic proteins. Also, in diploids, the reporters are less sensitive to 
transcription activation than they are in haploids, reducing the incidence of false 
positives from transactivating baits.  
 The human brain cDNA library was screened to identify new interacting 
partners for APP C-Terminal, in a phosphorylation-state dependent manner. The 
mating culture was observed under a phase-contrast microscope to check for the 
occurrence of zygotes (Fig. II.3), indicative that mating was occurring as 
expected. 
 
 
 
Figure II.3: Zygote formation in the 
mating mixture with its typical three-
lobed shape. The arrow is pointing the 
budding diploid cell. The other two lobes 
are the two haploid (parental) cells. This 
picture was taken using an inverted 
microscope in phase contrast mode, 
during the mating event (40X 
magnification). 
 
 
After plating the mating mixture in the appropriate selective media and 
waiting several days for colonies to appear, the growth on the control plates was 
scored and the mating efficiency and number of clones screened were calculated 
(Table II.2). 
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Table II.2: Results from the yeast two hybrid screen. 
Positive clones 
Mating efficiency 
(% diploids) 
Clones screened 
53 10% 1.1 X 108 
 
To calculate de number of clones screened the following equation was used [# cfu/ml of 
diploids X resuspension volume]. To calculate the mating efficiency the following equation 
was used [# cfu (in SD –Leu/-Trp) X 1000µl/ml/ volume plated (µl) x dilution factor] / [# 
cfu (in SD -Trp) X 1000µl/ml/ volume plated (µl) X dilution factor] X 100.  
 
 
II.4.2.2 Identification of AICDY687E interacting clones 
 
In the YTH screen 239 clones were isolated, 206 from SD/TDO and 33 from 
SD/QDO plates (Fig. II.4). All the colonies were re-streaked in SD/QDO plates in 
order to test for the expression of the nutritional reporter genes HIS3 and ADE2. 
These clones were further tested for MEL1 expression, another reporter gene, by 
growing these putative primary positive clones in SD/QDO media with X-? -Gal. 
True positive clones turn a blue colour (Fig. II.5), resulting in 55 true positive 
clones, thus identified in this screen. The positive clones were named CYE#. 
 
Figure II.4: Positive clones 
identified in the yeast two hybrid 
screen. The clones were recovered 
from the original SD/TDO or 
SD/QDO plates.  
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Figure II.5: MEL-1 expression 
test of the positive clones 
obtained in the YTH screen. Light 
blue colonies also represent 
positive interactions, but took 
longer to turn blue in the 
presence of X-? -GAL. 
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II.5 DISCUSSION 
 
As with all detection methods, the YTH system is known to result in the 
detection of some false positives. This was a relatively serious problem in the early 
days of the YTH method but the elimination of such false positive results has been 
greatly improved recently. False positive signals result from cells in which the 
reporter genes are active even though the bait and prey do not interact. There are 
several classes of false positives. For example, false positives may arise from prey 
that interact with DNA upstream of the reporter genes or with proteins that 
interact with promoter sequences. These two classes of false positives can be 
eliminated by the use of more than one reporter gene under the control of 
different promoters, as was the case with the present work. Another inherent 
problem with the system is that not all proteins will be efficiently folded and/or 
post-translationaly modified in the yeast nucleus, which may result in the protein 
not interacting with the true partner. In the same way, the protein may adopt a 
different tertiary structure when expressed as fusions with the transcription factor 
domains. Also, some proteins may be toxic when expressed as fusions in yeast, 
inhibiting growth when expressed at high levels. This can be avoided to some 
extent by the use of inducible expression plasmids. Other false positive results 
include interactions that occur in the YTH screen but not in a physiological 
context, because the partners are not expressed in the same cellular or subcellular 
environment at the same time. 
By screening 1.1 X 108 clones from a human brain cDNA library with 
AICDY687E as bait 55 positive clones were obtained as accessed by their ability to 
grow on SD/QDO selective media and to turn blue in the presence of X-a-Gal. 
Given the conditions of our screen, these should include the AICD interactome 
when the former is phosphorylated. At this stage however interactions should be 
validated and the protein interactions may be confirmed. As such, supplementary 
data from other sources should be used to evaluate the credibility of interactions 
in an YTH screen. Thereby, the verification of a putative interaction can be 
achieved in a variety of ways. One approach is to mix the recombinant proteins 
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and verify binding in vitro through a variety of biochemical assays. Another 
approach is to express both proteins in cells by transfection and analyse 
interactions by immunoprecipitation studies. However, even if co-
immunoprecipitation is successful, there is still the possibility that the proteins only 
interact under the conditions used. So, a crucial validation of the two-hybrid 
results is to prove that the two proteins exist in the same subcellular environment, 
by doing immunoprecipitation in the tissue of interest. 
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III CHARACTERIZATION OF THE POSITIVE 
CLONES 
 
 
III.1 INTRODUCTION  
 
The majority of the APP binding proteins that have been identified to date 
were discovered using the yeast Two-Hybrid (YTH) method. Often, when 
performing an YTH screen, only a few clones are selected and further 
characterized. Using such an approach many of the rarer positive clones are never 
analyzed, and some important potential interacting proteins may be missed. 
In this screen 55 positive clones were obtained and we decided to analyse all 
the positive clones in order to identify not only the most abundant clones but also 
the more interesting ones, even though they may have been detected only once 
or twice in the screen. This does not mean they are not important but may simply 
reflect the low abundance of the mRNA in the library used or its low abundance in 
the tissue from which the library was made.  
All positive clones were partially sequenced and some interactions were 
further confirmed. 
 
The use of YTH to support the Notch-like signalling of APP CHAPTER III 
68    Centro de Biologia Celular 
Universidade de Aveiro 
III.2 MATERIALS AND METHODS 
 
For the complete composition of all reagents, media and solutions used, 
see Appendix I. All reagents were cell culture grade or ultrapure. 
 
 
III.2.1 Plasmid isolation from yeast and transformation into 
bacteria 
 
“Breaking Buffer” Method 
Yeast plasmid DNA was extracted by resuspending cells in 0.2ml of 
breaking buffer, adding 0.3g of 0.5mm acid-washed glass beads plus 0.2ml 
25:24:1(v/v/v) phenol/chloroform/isoamyl alcohol and vortexing for 4 min before 
centrifuging for 5 min. The upper layer was transferred to a new microtube and 
once more, 0.2ml 25:24:1(v/v/v) phenol/chloroform/isoamyl alcohol were added, 
followed by vortexing for 2 min and centrifugation for 5 min. The upper layer was 
transferred to a new microtube and 0.2ml chloroform were added, vortexed for 1 
min and centrifuged for 5 min. The DNA in the upper layer was ethanol 
precipitated. 
 
“High Efficiency Yeast Plasmid Rescue” Method  
An alternative method was used for isolating yeast plasmid DNA: 3ml of 
yeast cells were pelleted and the DNA extracted using the QUIAGEN kit. The pellet 
was resuspended in 250µl of buffer P1, added about 250µl of 0.5mm acid-washed 
glass beads and vortexed on high for 5 min. Afterwards, 250µl of buffer P2 were 
added and the microtube was mixed by gently inverting until the solution became 
viscous and slightly clear. Then 350µl of buffer N3 were added and the microtube 
was repeatedly inverted until the solution became cloudy. The microtube was 
centrifuged for 10 min and the resulting supernatant was applied to a QIAprep 
spin column placed in a microtube. After a 1 min centrifugation the flow-through 
The use of YTH to support the Notch-like signalling of APP CHAPTER III 
Centro de Biologia Celular      69 
Universidade de Aveiro 
was discarded. The column was washed by adding 0.75ml of buffer PE and 
centrifuging 1 min to discard the flow-through. The column was centrifuged for an 
additional 1 min to remove residual wash buffer. Finally, the column was placed in 
a clean microtube and 50µl of H2O were added to elute the DNA by centrifuging 
for 1 min having let it stand for 1 min. 
Both methods were performed to carry out yeast plasmid extraction, the 
Breaking buffer method was extensively used, except for clones CYE163, CYE166 
and CYE174, in an attempt to improve the transformation efficiency. 
Plasmid DNA was transformed in E. coli XL1-Blue competent cells and 
plasmid DNA was isolated from single colonies as described in sections II.2.1.8-9. 
 
 
III.2.2 Analysis of the positive plasmids by restriction digestion, 
sequencing and database searching  
 
Plasmid DNA was digested with the restriction endonuclease Hind III, and 
fragments produced were separated by agarose gel electrophoresis as described 
in Chapter II.  
The vector used (pACT-2) produced a characteristic pattern of fragments 
that allowed its differentiation from colonies resulting from transformation by the 
bait vector. Plasmids generating DNA fragments characteristic of the pACT-
2+library insert digested with Hind III were further sequenced. Sequencing was 
performed as described in section II.2.1.12, using GAL4-AD primer (Clontech). 
A search for similar sequences in the Genbank database was performed 
using the BLAST algorithm (Basic Local Alignment Search Tool) (Altschul et al., 
1990). 
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III.2.3 Verifying protein interactions in yeast by yeast mating  
 
To verify protein interactions, yeast mating was performed combining the 
bait plasmid pAS-CYE in Y187 with the AD/library positive clones in AH109. 
Additional Two-Hybrid tests were carried out with the wild-type AICD and the 
AICDY687F, to compare the relative strength of the interaction. The AICDY687F 
mutant mimics the dephosphorylated state of Y-687. To achieve this assays, wild-
type AICD cDNA and AICDY687F cDNA were inserted in PAS2-1 vector, in frame 
with GAL4-BD (named pAS-CWT and pAS-CYF, respectively) and transformed in 
Y187 yeast strain (data not shown).  
The AD/library plasmids to be tested were transformed into AH109 and 
selected on SD/-Leu. For each one, pair wise yeast matings were set up with Y187 
containing the plasmids pAS-CWT, pAS-CYF and the bait pAS-CYE. One colony of 
each type were combined in 1.5ml YPD medium, vortexed and incubated at 30ºC 
for 24 hrs with shaking (180 rpm). A 100µl aliquot of each mating culture was 
spread on SD/-Trp/-Leu and incubated at 30ºC for 3 days to allow diploid cells to 
form visible colonies. 
To confirm protein-protein interactions, the fresh diploid colonies were 
assayed for growth on SD/QDO plates and for X-a-Gal activity. 
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III.3 RESULTS 
 
III.3.1 Preliminary analysis of the positive clones 
 
In order to identify the library insert present in a given positive clone, the 
plasmid DNA was first isolated from yeast. Thus, a mixture of different plasmid 
DNAs can be isolated from a single yeast clone, namely the bait plasmid (Figure 
III.1, lanes 3 or 4) and one or more library plasmids (Figure III.1, lane 6), being 
that each yeast cell can incorporate more than one library plasmid. Hence, in 
order to obtain single plasmids and pure DNA for sequence analysis, the plasmid 
DNA isolated from yeast cells was used to transform E. coli XL1-Blue. The plasmid 
DNA obtained from the resulting transformants was further analysed by restriction 
digestion with endonuclease Hind III. The restriction fragments were then 
separated by agarose gel electrophoresis. Figure III.1 exemplifies a typical result 
obtained after this procedure:  
 
 
 
Figure III.1: Hind III restriction analysis of 
yeast two hybrid plasmids. Lanes: 
1, 7: 1Kb ladder marker; 
2: pAS2-1 vector (4.6+2.2+0.9+0,7 Kb); 
3: pAS-CYE bait plasmid (4.6+2.2+0,9 Kb); 
4: pACT-2 vector (7.4+0.7Kb); 
5: pACT-2+library insert CYE12 (7.4+(0.7+ 
~2.8 insert)Kb); 
6: pACT-2+library insert CYE189 (7.4+(0.7+ 
~0.7 insert)Kb). 
 
The same strategy was adopted for each positive clone. After identifying 
transformants carrying the cDNA library plasmids, their respective inserts were 
sequenced with the GAL4-AD primer (Appendix II). Figure III.2 is a representative 
example obtained with one of the positive clones, CYE12: 
1      2      3      4      5      6      7 
bp
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Figure III.2: Nucleotide sequence of the positive clone CYE12. The yellow shaded area 
limits the vector pACT-2 and the library linker “GCGGCCGCGTCGAC”. 
 
The nucleotide sequence of each clone was then converted to FASTA 
format (Fig. III.3). In this format, in the first line the signal “>” precedes the 
name or additional information on the sequence and the sequence itself starts on 
the second line. 
 
 
 
 
 
 
 
 
 
 
 
Figure III.3: Sequence of clone CYE12 in the FASTA format.  
 
The sequence in FASTA format was then copied to the BLAST window 
(www.ncbi.nlm.nih.gov/BLAST/) (Fig. III.4A) to be compared with the GenBank 
Database of nucleotide sequences. The identity of the positive clones isolated was 
>CYE12sequence 
GGGGACTCGGCCCTGAACGAGCAGGAGAAGGAGTTGCAGCGGCGGCTGAAGCGTCTCTAC 
CCGGCCGTGGACGAACAAGAGACGCCGCTGCCTCGGTCCTGGAGCCCGAAGGACAAGTTC 
AGCTACATCGGCCTCTCTCAGAACAACCTGCGGGTGCACTACAAAGGTCATGGCAAAACC 
CCAAAAGATGCCGCGTCAGTTCGAGCCACGCATCCAATACCAGCAGCCTGTGGGATTTAT 
TATTTTGAAGTAAAAATTGTCAGTAAGGGAAGAGATGGTTACATGGGAATTGGTCTTTCT 
GCTCAAGGTGTGAACATGAATAGACTACCAGGTTGGGATAAGCATTCATATGGTTACCAT 
GGGGATGATGGACATTCGTTTTGTTCTTCTGGAACTGGACAACCTTATGGACCAACTTTC 
ACTACTGGTGATGTCATTGGCTGNTGNGNTAATCTTATCAACAATACCTGCTTTTACNCC 
AAGAATGGACATAGTTAAGGTATTGCTTTCCCTGACCTACCCCCAANTTGTATCCTACTG 
NGGGGCTTTNAACCCCAGGANAAGGGTCGATGCCAANTTTGGGCAAATCCTTTCNGTTTG 
ANAAAAAAAATNTTGCNGGGGNGGGNAACCNAATCCNGCCAAANANATCGATTTCNTTCG 
AAATCGAAGGAAAANGGCNACCTTTNCCAAAAAGGTTNCNTTTTTANCCCCCGGGTCTGG 
NCCAAAAAGCCTTTCAATTNAAANCAACGTTTAAAAATTNTNCTTNAAAANAAAATNAAA 
TTGTTTCCGGAAAGGAG 
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thus obtained. Figure III.4B shows a representative example of the results 
obtained for clone CYE12. 
 
 
 
 
 
Figure III.4: A, Blast window to introduce the query sequence; B, Blast results. 
 
 
III.3.2  Identification of the positive clones 
 
Of the original 55 positive clones identified in the YTH screen, 53, were 
recovered and definitively identified by partial or full DNA sequence analysis. The 
results obtained are summarized in Table III.1. 
Analysis of the 53 positives resulted in the identification of nucleotide 
sequences that could be divided into the following categories: 
  26 Clones matching a protein coding sequence (cds); 
  26 Clones aligning with non-coding and other genomic sequences; 
  1 Mitochondrial clone. 
 
A) B) 
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Table III.1: Complete list of positive clones. 
Clone ID 
(CYE#) 
N. 
clones Selection Stringency Insert (Kb)  Chromosome 
known proteins 
1,9,10,12,13,14,17,25,40, 
48,54,57,71,75,160,192 16 Medium 2,8 6 
189,197 2 Medium 0,7 7 
8,31,38,127 4 Medium 0,5 1 
224,230,235 3 High 2,2 21 
5 1 Medium 3,2 5 
after CDS 
145 1 Medium 0,7 17 
84,92 2 Medium 1,3 17 
231 1 High 1,7 12 
2 1 Medium 0,5 2 
123 1 Medium 2,2 1 
153 1 Medium 0,9 1 
genomic 
51,53 2 Medium 1,5 X 
177 1 Medium 1,1 19 
239 1 High 1,8 17 
136 1 Medium 2,8 15 
82 1 High 3,1 12 
144,152,174 3 Medium 3,1 12 
237 1 High 1,8 12 
130 1 Medium 1,5 9 
4 1 Medium 1,3 9 
44,52 2 Medium 0.5 7 
105 1 Medium 1,8 5 
41,81,125 3 Medium 1,5 3 
83 1 Medium 2,8 2 
mitochondrial 
128 1 Medium 0,9  
not analysed 
166 1 Medium   
163 1 High   
 
 
The identified clones were divided in five groups: proteins already known 
although not associated with APP (orange panel), clones that align with known 
proteins but outside of the coding sequence (CDS) (green panel), clones present 
in the database only at the genomic level (blue panel), a mitochondrial DNA 
sequence (yellow panel) and clones that, despite all efforts, analysis was not 
possible (grey panel). All clones were subject to the same analysis. They were 
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partially or completely sequenced, special features of the amino acid sequence 
were searched for using Motif and Domain search databases. The existence of 
ESTs (expressed sequence tags) was also ascertained by database searching.  
Some of the positive clones identified were analyzed more thoroughly and 
these are discussed below. 
 
 
III.3.3 Clones aligning with non-coding and 3’-UTR sequences 
 
In various cases the searches performed did not reveal any homologies 
within the coding sequences (CDS) of know protein, or predicted gene product, for 
the sequenced insert portion of 26 clones (Table III.1, after CDS and genomic ). 
Of these, 19 showed significant similarity only to human genomic clones. The 
remaining 7 clones (Table III.1, in green) matched mRNA sequences, although 
aligning with the 3’-UTR (untranslated regions). 
The translation of these clones in all three forward reading frames revealed 
premature stop codons, therefore it may be possible that these small DNA 
fragments encode peptides with strong affinity to the C-terminal domain of APP. 
However, it cannot be ruled out that such a small peptide may instead interact 
directly with the GAL4-DNA Binding Domain. Further testing would be required to 
clarify this issue, such as co-expressing the plasmid with different bait proteins.  
 
 
III.3.4 Clones matching a protein CDS 
 
Of the 53 clones identified, 26 were assigned to known proteins (Table 
III.1, orange and yellow panels). The number of clones for each identified binding 
protein varied considerably, from 1 clone (CYE5) to 16 clones (e.g. CYE12) as 
discussed below. This group of clones include positives identified from high and 
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low stringency selection. The following sections address the characterization of 
these AICD interacting proteins.  
Despite being considered a false positive, the mitochondrial clone (Table 
III.1, yellow panel), which matches a protein CDS, will also be discussed in this 
section. 
 
 
Mitochondrial clone 
 
The clone CYE128, obtained from the medium stringency selection, was 
found to match a mitochondrial DNA sequence, encoding an insert assigned to the 
Citochrome Oxidase 1 gene (COX1). Translation using the standard genetic code 
revealed premature stop codons. Mitochondria have a specific genetic code, 
different from the standard one used by the nuclear translation machinery, and as 
a result some mitochondrial amino acid codons are read as stop codons in 
cytoplasmatic translation (Anderson et al., 1981). Hence, in order to be detected 
in a two-hybrid assay, the plasmid encoded inserts must be expressed in the 
cytoplasm as GAL4-AD fusion proteins and exported to the nucleus, where they 
interact with a GAL4-BD-bait fusion to activate reporter gene expression, 
mitochondrial translation is unlikely to be occurring. Mitochondrial clones 
(including citochrome oxidase and 16S rRNA) have previously been described as 
common false positives in two-hybrid screens (Serebriiskii et al., 2001). The 
presence of premature stops in all reading frames, corroborates the hypothesis 
that this clone is likely to be a false positive. 
 
 
SDHB 
 
Four positive clones (CYE8, CYE31, CYE38 and CYE127) were identified 
using the GenBank database as SDHB (succinate dehydrogenase complex subunit 
B), a component of Complex II of respiratory electron-tranport chain. SDHB is 
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localized in the mitochondrial inner membrane. Although SDHB a nuclear-encoded 
mitochondrial protein, the interaction with AICD is unlikely to occur in a 
physiologically relevant context, because the partners are not expressed in the 
same subcellular environment.  
 
 
RanBPM/RanBP9 
 
Sixteen out of the 53 identified clones encoded a fragment of the RanBPM 
protein (clones CYE1, CYE9, CYE10, CYE12, CYE13, CYE14, CYE17, CYE25, CYE40, 
CYE48, CYE54, CYE57, CYE71, CYE75, CYE160 and CYE192). The large cDNA 
fragment (approximately 2,8Kb) alignment was within the coding region, with the 
fusion protein being expressed in the correct reading frame. The first nucleotides 
after the linker sequence, GGG, encoded amino acid G-136, on the sequence with 
the NCBI accession number AB055311 (in green in Fig. III.5). The RanBPM gene 
maps to chromosome 6p23, and the RanBPM transcript is widely expressed, 
evaluating by EST (Expressed Sequence Tag) data. 
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                                                          ga 
agcagaggaggaaggagagaagaggtggaggtggccgcaggctgagtcgcggccgggatg 
                         M   
tccgggcagccgccgccgccgccgccgcagcagcagcaacagcagcagcagctgtcgccg 
S  G  Q  P  P  P  P  P  P  Q  Q  Q  Q  Q  Q  Q  Q  L  S  P 
ccaccgccggcggccttggccccagtctccggagtcgtcctgccggcgcccccggccgtc 
P  P  P  A  A  L  A  P  V  S  G  V  V  L  P  A  P  P  A  V 
agcgccggctcttctccggccggctcgcccggcggcggtgcgggcggcgaaggcttaggg 
S  A  G  S  S  P  A  G  S  P  G  G  G  A  G  G  E  G  L  G 
gccgcggcggccgccctgctcctccaccctccgccgccgccgcccccggccaccgcggcc 
A  A  A  A  A  L  L  L  H  P  P  P  P  P  P  P  A  T  A  A 
ccgccgcccccgccgccgcccccgcctccccctgcctcagcggctgcccccgccagcggg 
P  P  P  P  P  P  P  P  P  P  P  A  S  A  A  A  P  A  S  G 
ccgcccgctcccccgggccttgcagcgggccccggcccggctggaggggccccgacccca 
P  P  A  P  P  G  L  A  A  G  P  G  P  A  G  G  A  P  T  P 
gctctggtggcgggcagcagcgccgcggcccccttccctcacggggactcggccctgaac 
A  L  V  A  G  S  S  A  A  A  P  F  P  H  G  D  S  A  L  N 
gagcaggagaaggagttgcagcggcggctgaagcgtctctacccggccgtggacgaacaa 
E  .Q.E  K  E  L  Q  R  R  L  K  R  L  Y  P  A  V  D  E  Q 
gagacgccgctgcctcggtcctggagcccgaaggacaagttcagctacatcggcctctct 
E  T  P  L  P  R  S  W  S  P  K  D  K  F  S  Y  I  G  L  S 
cagaacaacctgcgggtgcactacaaaggtcatggcaaaaccccaaaagatgccgcgtca 
Q  N  N  L  R  V  H  Y  K  G  H  G  K  T  P  K  D  A  A  S 
gttcgagccacgcatccaataccagcagcctgtgggatttattattttgaagtaaaaatt 
V  R  A  T  H  P  I  P  A  A  C  G  I  Y  Y  F  E  V  K  I 
gtcagtaagggaagagatggttacatgggaattggtctttctgctcaaggtgtgaacatg 
V  S  K  G  R  D  G  Y  M  G  I  G  L  S  A  Q  G  V  N  M 
aatagactaccaggttgggataagcattcatatggttaccatggggatgatggacattcg 
N  R  L  P  G  W  D  K  H  S  Y  G  Y  H  G  D  D  G  H  S 
ttttgttcttctggaactggacaaccttatggaccaactttcactactggtgatgtcatt 
F  C  S  S  G  T  G  Q  P  Y  G  P  T  F  T  T  G  D  V  I 
ggctgttgtgttaatcttatcaacaatacctgcttttacaccaagaatggacatagttta 
G  C  C  V  N  L  I  N  N  T  C  F  Y  T  K  N  G  H  S  L 
ggtattgctttcactgacctaccgccaaatttgtatcctactgtggggcttcaaacacca 
G  I  A  F  T  D  L  P  P  N  L  Y  P  T  V  G  L  Q  T  P 
ggagaagtggtcgatgccaattttgggcaacatcctttcgtgtttgatatagaagactat 
G  E  V  V  D  A  N  F  G  Q  H  P  F  V  F  D  I  E  D  Y 
atgcgggagtggagaaccaaaatccaggcacagatagatcgatttcctatcggagatcga 
M  R  E  W  R  T  K  I  Q  A  Q  I  D  R  F  P  I  G  D  R 
gaaggagaatggcagaccatgatacaaaaaatggtttcatcttatttagtccaccatggg 
E  G  E  W  Q  T  M  I  Q  K  M  V  S  S  Y  L  V  H  H  G 
tactgtgccacagcagaggcctttgccagatctacagaccagaccgttctagaagaatta 
Y  C  A  T  A  E  A  F  A  R  S  T  D  Q  T  V  L  E  E  L 
gcttccattaagaatagacaaagaattcagaaattggtattagcaggaagaatgggagaa 
A  S  I  K  N  R  Q  R  I  Q  K  L  V  L  A  G  R  M  G  E 
gccattgaaacaacacaacagttatacccaagtttacttgaaagaaatcctaatctcctt 
A  I  E  T  T  Q  Q  L  Y  P  S  L  L  E  R  N  P  N  L  L 
ttcacattaaaagtgcgtcagtttatagaaatggtgaatggtacagatagtgaagtacga 
F  T  L  K  V  R  Q  F  I  E  M  V  N  G  T  D  S  E  V  R 
tgtttgggaggccgaagtccaaagtctcaagacagttatcctgttagtcctcgacctttt 
C  L  G  G  R  S  P  K  S  Q  D  S  Y  P  V  S  P  R  P  F 
agtagtccaagtatgagccccagccatggaatgaatatccacaatttagcatcaggcaaa 
S  S  P  S  M  S  P  S  H  G  M  N  I  H  N  L  A  S  G  K 
ggaagcaccgcacatttttcaggttttgaaagttgtagtaatggtgtaatatcaaataaa 
G  S  T  A  H  F  S  G  F  E  S  C  S  N  G  V  I  S  N  K 
gcacatcaatcatattgccatagtaataaacaccagtcatccaacttgaatgtaccagaa 
A  H  Q  S  Y  C  H  S  N  K  H  Q  S  S  N  L  N  V  P  E 
ctaaacagtataaatatgtcaagatcacagcaagttaataacttcaccagtaatgatgta 
L  N  S  I  N  M  S  R  S  Q  Q  V  N  N  F  T  S  N  D  V 
gacatggaaacagatcactactccaatggagttggagaaacttcatccaatggtttccta 
D  M  E  T  D  H  Y  S  N  G  V  G  E  T  S  S  N  G  F  L 
aatggtagctctaaacatgaccacgaaatggaagattgtgacaccgaaatggaagttgat 
N  G  S  S  K  H  D  H  E  M  E  D  C  D  T  E  M  E  V  D 
tcaagtcagttgagacgccagttgtgtggaggaagtcaggccgccatagaaagaatgatc 
S  S  Q  L  R  R  Q  L  C  G  G  S  Q  A  A  I  E  R  M  I 
cactttggacgagagctgcaagcaatgagtgaacagctaaggagagactgtggcaagaac 
H  F  G  R  E  L  Q  A  M  S  E  Q  L  R  R  D  C  G  K  N 
actgcaaacaaaaaaatgttgaaggatgcattcagtctactagcatattcagatccctgg 
T  A  N  K  K  M  L  K  D  A  F  S  L  L  A  Y  S  D  P  W 
aacagcccagttggaaatcagcttgacccgattcagagagaacctgtgtgctcagctctt 
N  S  P  V  G  N  Q  L  D  P  I  Q  R  E  P  V  C  S  A  L 
aacagtgcaatattagaaacccacaatctgccaaagcaacctccacttgccctagcaatg 
N  S  A  I  L  E  T  H  N  L  P  K  Q  P  P  L  A  L  A  M 
ggacaggccacacaatgtctaggactgatggctcgatcaggaattggatcctgcgcattt 
G  Q  A  T  Q  C  L  G  L  M  A  R  S  G  I  G  S  C  A  F 
gccacagtggaagactacctacattagctatgcatttcaagagctcacacttatattgtg 
A  T  V  E  D  Y  L  H  *  D                         
gcatatagtcaacatggaagtagaccagctctgctgatttgaaatttagattttttaaat 
tatgtactggggacaggtttttgtcgctttacattgcttcctagtttacagcatgatgca 
aatgattttctaacttagtgttaggagaaattattttccatctttaacctcttagttgtc 
taagagttaaatattactgaatttcagacgttcaaattgatcatcacaaatcctttaaaa 
caattacctaaaagaaaccaaaaatcctgccttctttgtgggggaggggggagagagggg 
aaggaaatggaacaagttgtgtttgtgttagcatgtgggtgatgtaaacttcaaattggg 
agatgttccgacccc 
 
Figure III.5: Nucleotide and amino acid sequence of RanBPM (Accession # AB055311). 
Highlighted in green is the first codon of the identified positive clone (CYE12). 
 
The RanBPM/RanBP9 protein (Ran binding protein 9) was initially identified 
in a two-hybrid screen using Ran as bait, where Ran is a small GTP binding protein 
involved in nuclear export and import, and spindle formation (Nakamura et al., 
1998). Overexpression of this protein induced microtubule nucleation, suggesting 
a role in microtubule assembly. The full-length RanBPM is a 90kDa protein of 729 
aa residues, possessing a long stretch of proline and glutamine residues in the N-
terminal region (Nishitani et al., 2001), and three signalling domains (SPRY, LisH 
and CTLH domains) (Fig. III.6).  
 
 
 
Figure III.6: Diagram of human RanBPM protein. 
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SPRY domains were originally identified on Ryanodine receptors and on the 
SP1A kinase. The SPRY domain is around 140 aa and its function is unknown, but 
it is thought to be involved in protein-protein interactions or RNA-binding. The 
suggested functions for some SPRY-containing proteins are RNA-binding, cell 
growth and differentiation (Ponting et al., 1997).  
Another important RanBPM domain is LisH (Lissencephaly type-1-like 
homology motif). The LisH motif is 33 aa long and the predicted secondary 
structure consists of two alpha-helices. LisH is likely to possess a conserved 
protein-binding function and it is present in several proteins involved in 
microtubule dynamics. These motifs are thought to contribute to the regulation of 
microtubule dynamics, by mediating dimerization or by binding microtubules or 
dynein heavy chain (Ponting et al., 1997; Emes and Ponting, 2001).  
C-terminally to LisH motif there is a predicted alpha-helical sequence of 
unknown function that is adjacent to the LisH motif in several proteins, termed 
CTLH (Ponting et al., 1997; Emes and Ponting, 2001). 
Additionally, protein interactions were verified by yeast mating of Y187 
harbouring the bait plasmid pAS-CYE with the AD/library positive clones in AH109. 
Further, YTH tests were carried out with the wild-type AICD and the AICDY687F, to 
compare the interaction (Fig. III.7): 
 
  
Figure III.7: X-? -Gal activity assay 
in SD/QDO plates of diploids with the 
bait plasmid pAS-CYE or pAS-CWT or 
pAS-CYF and the prey plasmid pACT2-
CYE12. 
 
 
The results indicate that RanBPM also interacts with both AICDWT and 
AICDY687F. The interaction strengths look similar, since the diploids grew and 
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develop the blue colour simultaneously. Quantitative analysis will be the logical 
next step. 
The full-length RanBPM is localized within the nucleus, perinuclear region 
and cytoplasm (Nishitani et al., 2001). Since its initial identification, other two-
hybrid assays have shown RanBPM interaction with several other proteins, and 
these interactions have been confirmed by independent methods. RanBPM 
interactors include, besides Ran-GTP, the androgen receptor, a steroid hormone 
receptor whose transactivational function is enhanced by RanBPM (Rao et al., 
2002), the nuclear protein HIPK2 (homeodomain-interacting protein kinase-2), a 
transcriptional repressor (Wang et al., 2002b); hMuskelin, HSMpp8 and a novel 
nuclear protein Twa1 (Umeda et al., 2003). hMuskelin, and Twa1 also possess the 
LisH and CTLH motifs involved in microtubule dynamics. RanBPM also interacts 
with USP11, being deubiquitinated specifically by this enzyme, that prevents its 
degradation (Ideguchi et al., 2002). RanBPM also binds to MET, the receptor 
protein-tyrosine kinase, activating the Ras-Erk-SRE (serum response element) 
signalling pathway by inducing Ras-GTP association and Erk 1/2 phosphorylation 
(Wang et al., 2002a). Denti et al. reported that RanBPM is a phophoprotein 
(phosphorylated on serine residues) that interacts with ß2 integrin LFA-1 in vivo 
and in vitro and co-localize at the cell membrane, suggesting a contribution of 
RanBPM to coupling LFA-1 and other integrins with intracellular signalling 
pathways (Denti et al., 2004). Immunoprecipitation of this protein from HeLa cells 
revealed a 670kDa protein complex that included very little Ran, possibly 
suggesting new roles for RanBPM/RanBP9 namely in nuclear transport. 
 
 
Transportin-SR2 
 
In the YTH screen, two out of 53 clones (CYE189 and CYE197 encoded a 
fragment of Transportin-SR2, a nuclear import receptor for SR proteins. The cDNA 
fragment (approximately 0,7Kb) alignment was observed to be within the coding 
region of isoform 2, with the fusion protein being expressed in the correct reading 
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frame. The first nucleotides in the library insert after the linker sequence, ATT, 
encoded amino acid I-803, on the sequence with the NCBI accession number 
NM_012470 (Fig. III.8). Transportin is also termed: TRN-SR, TRN-SR2, 
Transportin 3, TNPO3, Importin 12, IPO12. In this work the designation 
Tranportin-SR2 will be used. Transportin-SR2 is an alternative splicing product of 
TNPO3 gene. The Transportin-SR2 maps to chromosome 7q32. 
 
 
 
aa 
aggtatcggtgctgtcgcttccggtccgggtaaacgaaccttaggtacactggtgtgtgg 
cctcccaagataggcttctgagggcaagtcagcgactgaagacgggagcgccagaatctg 
tggactcaagagtctagaatcaagtggaaaaaccggaaaaaaggccaggaacctgaatac 
gacctaatagctgtttccgagggggcaacttccacggagaaccttctgccctggtaacgg 
ccaaagaggaggagatggcgccagtcagggagcggccgtggcccagacagtgaggaagcg 
cgaaggcggagcaaccgaggaatcctccggagaagaatcagagccgtcgctaccgccact 
            M  E  G  A  K  P  T  L  Q  L  V  Y  Q  A  V  Q   
accgccaccaccatggaaggagcaaagccgacattgcagctcgtgtaccaggcagtgcag 
A  L  Y  H  D  P  D  P  S  G  K  E  R  A  S  F  W  L  G  E   
gcgctttaccacgacccagatcccagcggaaaggagcgcgcctctttttggcttggggag 
L  Q  R  S  V  H  A  W  E  I  S  D  Q  L  L  Q  I  R  Q  D   
ctgcagcgttcggttcatgcatgggagatctcagaccagttgttacagatccggcaggat 
V  E  S  C  Y  F  A  A  Q  T  M  K  M  K  I  Q  T  S  F  Y   
gtggagtcatgctattttgctgcacagaccatgaaaatgaagattcagacctcattttat 
E  L  P  T  D  S  H  A  S  L  R  D  S  L  L  T  H  I  Q  N   
gagctccccacagactctcatgcctctttacgggactcattgctaacccatatccagaac 
L  K  D  L  S  P  V  I  V  T  Q  L  A  L  A  I  A  D  L  A   
ttgaaagacttgtcacctgttattgtaacgcagctggctttagcaatagcagatcttgcc 
L  Q  M  P  S  W  K  G  C  V  Q  T  L  V  E  K  Y  S  N  D   
ctacagatgccttcctggaagggatgtgtgcaaacactggtggaaaaatacagcaatgat 
V  T  S  L  P  F  L  L  E  I  L  T  V  L  P  E  E  V  H  S   
gtgacttctttgccttttttgctggagatccttacagtgttacctgaagaagtacatagt 
R  S  L  R  I  G  A  N  R  R  T  E  I  I  E  D  L  A  F  Y   
cgttccttacgaattggagctaatcggcgcacagaaattatagaagatttggccttctac 
S  S  T  V  V  S  L  L  M  T  C  V  E  K  A  G  T  D  E  K   
tctagtacagtagtatctctattgatgacctgtgtagaaaaagcaggaacagatgagaaa 
M  L  M  K  V  F  R  C  L  G  S  W  F  N  L  G  V  L  D  S   
atgcttatgaaggtttttcgctgtttgggaagttggtttaacttgggagttttggacagt 
N  F  M  A  N  N  K  L  L  A  L  L  F  E  V  L  Q  Q  D  K   
aacttcatggctaacaataaattactagcactcctttttgaggttttgcaacaggataag 
T  S  S  N  L  H  E  A  A  S  D  C  V  C  S  A  L  Y  A  I   
acctcgtctaacctacatgaagctgcttcggactgtgtatgctcagctctctatgccatt 
E  N  V  E  T  N  L  P  L  A  M  Q  L  F  Q  G  V  L  T  L   
gagaatgtggagactaacttgccattagccatgcaactttttcagggagtgctgacattg 
E  T  A  Y  H  M  A  V  A  R  E  D  L  D  K  V  L  N  Y  C   
gagactgcctatcatatggccgtggcacgtgaagatttagacaaagttctgaattactgc 
R  I  F  T  E  L  C  E  T  F  L  E  K  I  V  C  T  P  G  Q   
cgtattttcactgaactatgtgaaacttttcttgaaaaaattgtttgtactccaggccaa 
G  L  G  D  L  R  T  L  E  L  L  L  I  C  A  G  H  P  Q  Y   
ggtcttggggaccttcgaactctggagctgctgcttatctgtgcaggccatcctcaatat 
E  V  V  E  I  S  F  N  F  W  Y  R  L  G  E  H  L  Y  K  T   
gaggtagtagaaatttcatttaacttttggtaccgactgggggaacatttgtacaaaact 
N  D  E  V  I  H  G  I  F  K  A  Y  I  Q  R  L  L  H  A  L   
aacgatgaagttattcatggcatcttcaaagcttacattcagaggctgcttcacgccttg 
A  R  H  C  Q  L  E  P  D  H  E  G  V  P  E  E  T  D  D  F   
gctcgacactgccagctggaaccagaccatgagggggttcctgaggagactgatgacttt 
G  E  F  R  M  R  V  S  D  L  V  K  D  L  I  F  L  I  G  S   
ggggagtttcgcatgagggtatcagacctggtaaaggacttgattttcttgatagggtct 
M  E  C  F  A  Q  L  Y  S  T  L  K  E  G  N  P  P  W  E  V   
atggagtgttttgctcagttatattctactctgaaagaaggcaacccaccctgggaggtg 
T  E  A  V  L  F  I  M  A  A  I  A  K  S  V  D  P  E  N  N   
acagaagcggttctctttatcatggctgctatagcaaagagtgttgatccggaaaacaat 
P  T  L  V  E  V  L  E  G  V  V  R  L  P  E  T  V  H  T  A   
ccaacacttgtggaagtcctagaaggagttgtccgcctcccggagaccgtacatacggct 
V  R  Y  T  S  I  E  L  V  G  E  M  S  E  V  V  D  R  N  P   
gtgcgatacaccagcattgaattggttggagagatgagtgaagtcgttgatcgaaatcct 
Q  F  L  D  P  V  L  G  Y  L  M  K  G  L  C  E  K  P  L  A   
cagttccttgaccctgtgttgggctatttgatgaaaggcctgtgtgaaaagcccctggct 
S  A  A  A  K  A  I  H  N  I  C  S  V  C  R  D  H  M  A  Q   
tctgctgcagccaaagccattcataacatttgctctgtctgccgagatcacatggctcag 
H  F  N  G  L  L  E  I  A  R  S  L  D  S  F  L  L  S  P  E   
cactttaatggactcctggagattgcccgctccctcgattccttcctgttgtctccagaa 
A  A  V  G  L  L  K  G  T  A  L  V  L  A  R  L  P  L  D  K   
gctgctgtgggcttgctaaaagggacagcacttgtcctagcccgattacctttggataag 
I  T  E  C  L  S  E  L  C  S  V  Q  V  M  A  L  K  K  L  L   
attaccgaatgtcttagtgaactatgttctgttcaggttatggcattgaaaaagctgttg 
S  Q  E  P  S  N  G  I  S  S  D  P  T  V  F  L  D  R  L  A   
tctcaagagcccagcaatggcatatcctcagatcccacagtgttcttagatcgccttgca 
V  I  F  R  H  T  N  P  I  V  E  N  G  Q  T  H  P  C  Q  K   
gtgatatttaggcataccaatcccattgtggaaaatggacagactcatccgtgtcagaaa 
V  I  Q  E  I  W  P  V  L  S  E  T  L  N  K  H  R  A  D  N   
gtcatacaggaaatatggccagttttatccgagactctaaataagcaccgagctgataat 
R  I  V  E  R  C  C  R  C  L  R  F  A  V  R  C  V  G  K  G   
cggattgtagagcgttgttgcaggtgcctgcgctttgctgttcgctgtgtaggcaaagga 
S  A  A  L  L  Q  P  L  V  T  Q  M  V  N  V  Y  H  V  H  Q   
tctgcagcactgctgcagccactagtcacacagatggtgaatgtgtaccacgtacatcag 
H  S  C  F  L  Y  L  G  S  I  L  V  D  E  Y  G  M  E  E  G   
cattcctgcttcctgtaccttggcagtatccttgtggatgaatatggcatggaagaaggc 
C  R  Q  G  L  L  D  M  L  Q  A  L  C  I  P  T  F  Q  L  L   
tgtcggcagggactgctagacatgctccaggcactgtgcatccccacctttcagctccta 
E  Q  Q  N  G  L  Q  N  H  P  D  T  V  D  D  L  F  R  L  A   
gaacagcagaatggtctccagaatcaccctgacactgtagatgacctgttccggctagcc 
T  R  F  I  Q  R  S  P  V  T  L  L  R  S  Q  V  V  I  P  I   
accaggtttattcagcgtagccctgtcaccttgctgcggagccaagtggtcatccctatc 
L  Q  W  A  I  A  S  T  T  L  D  H  R  D  A  N  C  S  V  M   
ttacagtgggccattgcctctactaccctggaccaccgggatgccaattgtagtgtcatg 
R  F  L  R  D  L  I  H  T  G  V  A  N  D  H  E  E  D  F  E   
aggtttctacgagacctcattcatacaggggtagccaatgatcatgaagaagactttgaa 
L  R  K  E  L  I  G  Q  V  M  N  Q  L  G  Q  Q  L  V  S  Q   
ttacggaaagaactgattggacaggtgatgaaccagcttggacagcagcttgtcagccag 
L  L  H  T  C  C  F  C  L  P  P  Y  T  L  P  D  V  A  E  V   
ctgctgcacacctgctgcttttgcctccccccctataccctaccagatgtggctgaagtg 
L  W  E  I  M  Q  V  D  R  P  T  F  C  R  W  L  E  N  S  L   
ctctgggagatcatgcaggttgacagaccgactttttgtcgatggttagaaaattcctta 
K  G  L  P  K  E  T  T  V  G  A  V  T  V  T  H  K  Q  L  T   
aaaggtttgccaaaggaaacaaccgtgggagccgtcacagtgacacacaaacaacttaca 
D  F  H  K  Q  V  T  S  A  E  E  C  K  Q  V  C  W  A  L  R   
gacttccacaagcaagtcactagtgctgaggaatgtaaacaagtttgctgggccttgcga 
D  F  T  R  L  F  R  *  
gacttcaccaggttgtttcgatagctcacactcctgcactgtgcctgtcacccaggaatg 
tcttttttaattagaagacaggaagaaaacaaaaaccagactgtgtcccacaatcagaaa 
cctccgttgtggcagaggggccttcaccgccaccagggtgtcccgccagacagggagaga 
ctccagccttctgaggccatcctgaggagttcctgtttgggggtgtgagggaaaatcagc 
gcggattttaaaaagatggctgtggcctgcccggcgtggtgggaggggagctggtttcct 
ggtgaactttctaaaaggaaaaataattttaagtaaagaaaaaagaaaaaaaaggaagac 
taaacagaaaccagaactgaaacattcacctggtagcaaatgacacatgcacgcacacac 
acatacacgcacaagcgccagtgcgcacgtgtacacagaaaaacaaaaggacaagctttc 
tgtgaaacaaaatatttacttagggataatgtggggattcacatgaattaaatagctgca 
attggaa   
 
Figure III.8: Nucleotide and amino acid sequence of Transportin -SR2, isoform 2 
(Accession # NM_012470). Highlighted in green is the first codon of the identified positive 
clone (CYE189). 
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The full-length Transportin-SR2 is a 104kDa protein of 923 amino acids, 
possessing a long RS domain interaction in its C-terminal region. RS domains are 
domains with Arginine/Serine dipeptide repeats and proteins containing RS 
domains are known as SR proteins (Allemand et al., 2002). Transportin-SR2 has a 
region that shares similarities with human exportin-t and another region similar to 
importin-? 1 and RanBP5 (Fig. III.9) (Lai et al., 2000). 
 
 
 
 
 
Figure III.9: Diagram of human Transportin-SR2, isoform 2.  
 
 
 
The novel identified protein interaction between our bait and Transportin-
SR2 was verified by yeast mating. Additional YTH tests were carried out with the 
wild-type AICD and the AICDY687F, to compare the interaction. The results indicate 
that Transportin-SR2 also interacts with both AICDWT and AICDY687F. The 
interaction strength looks similar, since the diploids grew and developed the blue 
colour simultaneously (Fig. III.10). 
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Figure III.10: X-? -Gal activity 
assay in SD/QDO plates of diploids 
with the bait plasmid pAS-CYE or 
pAS-CWT or pAS-CYF and the 
prey plasmid pACT2-CYE189, 
identified as Transportin-SR2. 
 
 
Transportin-SR2 is localized in the cytoplasm and in the nucleus, and 
belongs to the Importin-? /transportin protein family. It was demonstrated to 
interact in vitro with phosphorylated, but not with unphosphorylated, RS domains 
(domains with Arginine/Serine dipeptide repeats) (Lai et al., 2000; Allemand et al., 
2002). SR proteins, which contain RS domain(s), are mainly involved in the 
splicing of precursor mRNA and in other aspects of gene expression (Kataoka et 
al., 1999). 
Translocation of macromolecules across the nuclear envelope occurs 
through the nuclear pore complex (NPC) and requires additional factors, such as 
Ran (small GTPase) and NTF2. Cargoes possessing a prototypical nuclear 
localization signal (NLS) (cluster(s) of basic residues) are recognized by importin-
? , which in turn interacts with importin-?  for NPC docking. Non-typical NLS (e.g. 
Gly-rich, Arg-rich) interact directly with the corresponding import receptor. 
Receptor-cargo complexes subsequently dock on the cytoplasmic part of NPC and 
then translocate through the pore into the nucleus. The RS domain acts as the 
NLS for SR proteins (Poon and Jans, 2005). 
To date, Transportin-SR2 interacting proteins comprise the splicing factors 
SFRS1 and SFRS2 (only with the phosphorylated-state) and NUP62, a nuclear pore 
glycoprotein. Transportin-SR2 was recently reported to also interact with several 
non-SR proteins (Lai et al., 2003), directing them to an import pathway to the 
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nucleus identical to SR proteins. For instance RBM4, a pre-mRNA splicing 
regulator, was shown to interact with Transportin-SR2, in a Ran-sensitive manner 
(Lai et al., 2003). 
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III.4 DISCUSSION 
 
In the YTH screen several positive clones corresponded to independent hits 
on the same protein, therefore the AICDY687E interactome comprised 5 different 
proteins. Interestingly, the most abundant interaction detected for AICDY687E was 
towards a single protein. Thus, 16 positives out of the 53 identified clones 
encoded RanBP9/RanBPM protein.  
Two positive clones encoded a fragment of the nuclear import receptor 
Transportin-SR2. The number of hits on this protein, compared with RanBPM, may 
denote that either Transportin-SR2 mRNA was less expressed in the tissues used 
to produce the cDNA library or the interaction of AICD with Transportin-SR2 is not 
so strong as with RanBPM. 
Four positives were identified as SDHB. Although being a nuclear-encoded 
protein, SDHB is localized in the mitochondrial inner membrane, as a result this 
interaction is unlikely to occur in a physiological context, because the partners are 
not expressed in the same subcellular environment. However, the number of hits 
for this protein and given that it is associated with oxidative stress in AD (Bubber 
et al., 2005), suggest that SDHB may potentially be an interesting clone.  
None of the previously identified APP binding proteins were isolated in this 
YTH screen, probably due to the fact in the AICD bait Tyrosine-687 is mutated to 
Glutamate. Nevertheless RanBPM and Transportin-SR2 were shown to interact 
also with wild-type AICD and phosphomutant AICDY687F. 
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IV DISCUSSION AND CONCLUSIONS 
 
 
Adequacy of the YTH strategy 
 
Of the 1.1x108 clones screened 55 positives clones were isolated. Of these, 
2 could not be sequenced. Of the remaining 53 library plasmids analysed, 16 were 
single hits, but only 4 of these arose from the high stringency selection. Only 5 
different proteins were found inside the CDS in the correct reading frame. Among 
the analysed positive clones, two proteins were found that have central roles in 
nuclear targeting, RanBPM and Transportin-SR2. Despite the intrinsic limitations of 
YTH, these results confirm that it is an important tool for identifying new proteins 
that interact with a protein of interest. However, this method requires some 
caution in the analysis of the results, and one should be aware of its limitations 
when discussing the cellular significance of the detected interactions. 
The present screen identified many DNA sequences, several of which did 
not match predicted protein sequences or even protein motifs. These interacting 
peptide sequences may in the future be analysed to reveal a specific AICD binding 
motif. The occurrence of mitochondrial clones might simply reflect the presence of 
similar peptide sequences in the multiple short mitochondrial fusion proteins. 
The recovery of two distinct library plasmids from the same clone is likely to 
happen, because in the library transformation, yeast can occasionally acquire 
more than one plasmid after several rounds of cell division even without selective 
pressure. This situation was overcome by restreaking the clones 2 or 3 times, thus 
selecting for the plasmids that allow the cells to grow on the selective culture 
media used. Nevertheless, in order to verify that an isolated plasmid is responsible 
for the interaction, it should be tested by mating in suitable yeast strains of 
opposite mating type, thus confirming reporter expression of the resulting diploids. 
This procedure was carried out for the selected positive clones CYE12 (RanBPM) 
and CYE189 (Transportin-SR2). Subsequently to characterization of positive 
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clones, all interactions need to be confirmed by a different method, usually 
coimmunoprecipitation of cellular extracts using specific antibodies to the 
interacting partners. 
To confirm interactions with the complete APP protein, the full-length 
sequence can also be used in similar assays to confirm interaction with the cellular 
protein. These will be forthcoming. The YTH may also be used to test the effect of 
phosphorylation in the novel interactions reported here with AICD, by verifying the 
interaction with AICDWT and AICDY687F phosphomutant. Both RanBPM and 
Transportin-SR2 interact with AICDWT, AICDY687E and AICDY687F as showed by the 
positive X-? -Gal assays. To detect slightly differences in these interactions, a 
quantitative X-Gal assay should be subsequently carried out. 
Another important validation of the putative interactions discovered is the 
confirmation of coexpression of the two binding partners either in the same cell- 
type or in the same subcellular compartment. As already mentioned, a condition 
for in vivo interaction of two proteins is their simultaneous presence in the same 
subcellular compartment. It is therefore important to determine the subcellular 
location where these proteins are present, the particular structures they associate 
with and, mainly in case of proteins involved in AD, their expression levels in AD 
samples. For example, SDHB, which is a nuclear-encoded protein localized in the 
mitochondrial inner membrane, is improbable to interact with AICD in a 
physiological context, because they are not expressed in the same subcellular 
compartment. Although the activity of SDHB was reported to increase in AD 
(Bubber et al., 2005) the interaction of AICD with SDHB is more likely to be a false 
positive. The same happens with the mitochondrial clone CYE128, which codes for 
Cytochrome c oxidase, since the activity of this enzyme was reported to decrease 
in AD platelets (Cardoso et al., 2004). 
 
 
 
 
 
The use of YTH to support the Notch-like signalling of APP CHAPTER IV 
Centro de Biologia Celular      89 
Universidade de Aveiro 
Two novel interactions relevant for AICD nuclear targeting  
 
Here we report two novel interactions for AICD, which relative to previously 
described interactions were found to have central roles in nuclear targeting, 
RanBPM and Transportin-SR2.  
Among the proteins reported to bind RanBPM, several are important 
signalling molecules, thus by its interaction with AICD it links the latter to 
receptor-mediated signalling pathways. RanBPM, for instance, through binding to 
the cytoplasmic domain of Integrin LFA-1, may constitute a molecular scaffold to 
coupling integrins with intracellular signalling pathways. Additionally, RanBPM was 
also reported to bind MET, activating the Ras/Erk signalling pathway. Upon 
activation, the Erks phosphorylate cytoplasmic targets and translocate to the 
nucleus were they activate transcription factors. By interacting with RanBPM, AICD 
may be involved in this signalling cascade. Furthermore, sAPP has been shown to 
increase MAP kinase activity and tyrosine phosphorylation in a Ras-dependent 
manner (Greenberg et al., 1994). Concomitantly, RanBPM binds Ran that belongs 
to the Ras superfamily and plays a role in the translocation of proteins trough the 
nuclear pore complex. Of relevance to AD in the fact that the N-terminus of 
RanBPM, which is required for recruiting Sos and Ras activation, has a Poly-PQ 
stretch. This stretch of proline and glutamine residues have the tendency to 
aggregate, forming aggresomes.  
The novel interaction reported in this thesis between AICD and Transportin-
SR2 provides supportive evidence for mediated nuclear import of AICD through 
the nuclear pore complex. Therefore AICD is likely to be a novel Transportin-SR2 
cargo, even though it harbours no RS dipeptide repeats, thus adding further  
insights to the nuclear import of AICD. Transportin-SR2-mediated nuclear import 
can also be regulated by Ran, since GTP-bound Ran is known to dissociate cargo 
from importin-? . For instance RBM4, a pre-mRNA splicing regulator, interacts with 
Transportin-SR2 in a Ran-sensitive manner, in which Ran-GTP abolishes the 
binding of RBM4 to Transportin-SR2.  
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In the present YTH screen we report two novel AICD interacting proteins, 
RanBPM and Transportin-SR2. In our model (Fig. IV.1) AICD is a cargo for 
Transportin-SR2 import receptor. The latter docks on nucleoporins and 
translocates through the nuclear pore. Presumably AICD does not go through 
facilitated diffusion because it is complexed with RanBPM. At the nucleoplasmic 
side of the nuclear pore complex, Ran-GTP, which binds RanBPM, dissociates 
Transportin-SR2 and nucleoporins. These protein-protein interactions may target 
AICD to the nucleus and link it to signal transduction pathways, culminating in 
gene transcription events. 
 
 
Figure IV.1: Putative model of a nuclear import complex. 
 
This data supports the functional similarity between AICD and the 
intracellular domain of transmembrane proteins, such as Notch, that are released 
by ?-secretase cleavage and migrate to the nucleus to regulate gene transcription. 
AICD was already reported to migrate to the nucleus complexed with FE65 and 
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Tip60 to activate specific gene targets, such as KAI1/CD82 (Cao and Sudhof, 
2001; Baek et al., 2002; Telese et al., 2005). Our data provide further evidence as 
to how AICD nuclear import is mechanistically carried out and suggest that AICD 
migration to the nucleus can potentially be achieved in absence of FE65.  
Together RanBPM and Transportin-SR2 suggest that the AICD fragment 
released after ?-secretase cleavage is involved in multiple signalling pathways by 
means of protein-protein interactions, which target AICD to the nucleus in a 
Notch-like manner. As such the such the work here described brings us nearer to 
unravelling the physiological functions of APP. This in turn is of potential 
significant relevance in the pathology of AD, for the design of effective therapeutic 
strategies. 
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Appendix I - Culture media and solutions 
 
 
Bacterial Media 
 
? LB (Luria-Bertani) Medium 
To 950ml of deionised H2O add: 
LB 25g 
Agar 12g (for plates only) 
Shake until the solutes have dissolved. Adjust the volume of the solution to 
1 liter with deionised H2O. Sterilize by autoclaving. 
 
? SOB Medium 
To 950ml of deionised H2O add: 
Bacto-tryptone 20g 
Bacto-yeast extract 5g 
NaCl 0.5g 
Shake until the solutes have dissolved. Add 10ml of a 250mM KCl (prepared 
by dissolving 1.86g of KCl in 100ml of deionised H2O). Adjust the pH to 7.0 with 
5N NaOH. Adjust the volume of the solution to 1 liter with deionised H2O. Sterilize 
by autoclaving. Just prior to use add 5ml of a sterile solution of 2M MgCl2 
(prepared by dissolving 19g of MgCl2 in 90ml of deionised H2O; adjust the volume 
of the solution to 100ml with deionised H2O and sterilize by autoclaving). 
 
? SOC Medium 
SOC is identical to SOB except that it contains 20mM glucose. After the SOB 
medium has been autoclaved, allow it to cool to 60ºC and add 20ml of a sterile 
1M glucose (this solution is made by dissolving 18g of glucose in 90ml of 
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deionised H2O; after the sugar has dissolved, adjust the volume of the solution to 
100ml with deionised H2O and sterilize by filtration through a 0.22-micron filter). 
Yeast Media 
 
 
? 10X dropout solution (DO10X) 
 This solution contains all but one or more of the following components: 
             10X concentration (mg/L)    SIGMA # 
L-Isoleucine     300       I-7383 
L-Valine     1500      V-0500 
L-Adenine hemisulfate salt   200      A-9126 
L-Arginine HCl    200      A-5131 
L-Histidine HCl monohydrate  200      H-9511 
L-Leucine     1000      L-1512 
L-Lysine HCl     300      L-1262 
L-Methionine     200      M-9625 
L-Phenylalanine    500      P-5030 
L-Threonine     2000      T-8625 
L-Tryptophan    200      T-0254 
L-Tyrosine     300      T-3754 
L-Uracil     200      U-0750 
 
10X dropout supplements may be autoclaved and stored for up to 1 year. 
 
? YPD medium 
 To 950ml of deionised H2O add:  
20g Difco peptone  
 10g Yeast extract  
 20g Agar (for plates only) 
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 Shake until the solutes have dissolved. Adjust the volume to 1L with 
deionised H2O and sterilize by autoclaving. Allow medium to cool to 60ºC and add 
glucose to 2% (50ml of a sterile 40% stock solution).  
 
? SD synthetic medium 
 To 800ml of deionised H2O add:  
6.7g Yeast nitrogen base without amino acids (DIFCO)  
 20g Agar (for plates only) 
 Shake until the solutes have dissolved. Adjust the volume to 850ml with 
deionised H2O and sterilize by autoclaving. Allow medium to cool to 60ºC and add 
glucose to 2% (50ml of a sterile 40% stock solution) and 100ml of the appropriate 
10X dropout solution. 
 
 
? 2X YPDA 
 Prepare YPD as above. After the autoclaved medium has cooled to 55ºC 
add 15ml of a 0.2% adenine hemisulfate solution per liter of medium (final 
concentration is 0.003%). 
 
 
Solutions 
 
? 50X TAE Buffer 
 242g Tris base 
 57.1ml glacial acetic acid 
 100ml 0.5M EDTA (pH 8.0) 
 
? TE Buffer (pH 7.5) 
10mM Tris-HCl (pH 7.5) 
1mM EDTA, pH 8.0 
The use of YTH to support the Notch-like signalling of APP APPENDIX 
110    Centro de Biologia Celular 
Universidade de Aveiro 
? Competent Cell Solutions: 
 
Solution I (1L):  
9.9g MnCl2.4H2O 
1.5g CaCl2.2H2O 
150g glycerol 
30ml KHAc 1M; 
adjust pH to 5.8 with HAc, filter through a 0.2µm filter and store at 
4ºC 
 
Solution II (1L): 
20ml 0.5M MOPS (pH 6.8) 
1.2g RbCl, 11g CaCl2.2H2O 
150g glycerol;  
filter through a 0.2µm filter and store at 4ºC  
 
 
? Miniprep Solutions: 
Solution I:  
50mM glucose 
25mM Tris.HCl (pH 8.0) 
10mM EDTA 
Solution II: 
0.2N NaOH 
1%SDS  
Solution III: 
3M potassium acetate 
2M glacial acetic acid 
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? Megaprep Solutions: 
 Cell Resuspension Solution: 
50 mM Tris-HCl (pH 7.5) 
10 mM EDTA 
100 µg/ml RNAase A  
Cell Lysis Solution:  
0.2 M NaOH 
1% SDS 
Neutralization solution: 
1.32 M potassium acetate (pH 4.8) 
Column Wash Solution: 
80 mM potassium acetate 
8.3 mM Tris-HCl (pH 7.5) 
40µM EDTA 
55% ethanol 
 
 
SDS-PAGE Solutions  
 
? LGB (Low Gel Buffer) 
 To 900ml of deionised H2O add:  
181.65g Tris  
 4g SDS  
 Shake until the solutes have dissolved. Adjust the pH to 8.9 and adjust the 
volume to 1L with deionised H2O. 
 
? UGB (Upper Gel Buffer) 
 To 900ml of deionised H2O add:  
75.69g Tris  
 Shake until the solute has dissolved. Adjust the pH to 6.8 and adjust the 
volume to 1L with deionised H2O. 
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? 30%Acrylamide/0.8% Bisacrylamide 
 To 70ml of deionised H2O add: 
 29.2g Acrylamide  
 0.8g Bisacrylamide  
 Shake until the solutes have dissolved. Adjust the volume to 100ml with 
deionised H2O. Store at 4ºC. 
 
? Loading Gel Buffer 
250mM Tris-HCl (pH 6.8) 
8% SDS 
40% Glycerol 
2% 2-mercaptoethanol 
0.01% Bromophenol blue 
 
?1X Running Buffer 
25mM Tris-HCl (pH8.3) 
250mM Glycine 
0.1% SDS 
 
?1X Transfer buffer 
25mM Tris-HCl (pH8.3) 
192mM Glycine 
20% Methanol 
 
 
?10X TBS  
10mM Tris-HCl (pH 8.0) 
150mM NaCl 
 
?10X TBST 
10mM Tris-HCl (pH 8.0) 
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150mM NaCl 
0.05% Tween 
 
 
Yeast Two-Hybrid Solutions 
 
? Yeast plasmid rescue – Breaking buffer 
2% Triton X-100 
1% SDS 
100mM NaCl 
10mM Tris-HCl (pH 8.0) 
 
? Solutions for preparation of yeast protein extracts 
a) Protease inhibitor solution 
Always prepare solution fresh just before using. Place on ice to prechill. To 
prepare 688µl add in a microfuge tube: 
66µl Pepstatin A (1mg/ml stock solution in DMSO) 
2µl Leupeptin (10.5mM stock solution) 
500µl Benzamidine (200mM stock solution) 
120? l Aprotinin (2.1mg/ml stock solution) 
 
b) PMSF (phenylmethyl-sulfonyl fluoride) stock solution (100X) 
Dissolve 0.1742g of PMSF (SIGMA) in 10ml isopropanol. Wrap tube in foil 
and store at RT. 
 
c) Cracking buffer stock solution 
 To 80ml of deionised H2O add:  
 48g Urea  
 5g SDS 
 4ml 1M Tris-HCl (pH6.8) 
 20? l 0.5M EDTA  
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 40mg Bromophenol blue  
Shake until the solutes have dissolved. Adjust the volume to 100ml with 
deionised H2O. 
d) Cracking buffer 
To prepare 1.13ml add in a microfuge tube: 
1ml Cracking buffer stock solution (recipe above) 
10? l ß-mercaptoethanol  
70? l Protease inhibitor solution (recipe above) 
50? l 100X PMSF stock solution 
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 Appendix II - Primers  
 
PRIMER SEQUENCE (5’:::: 3’) Nt  
No. 
MT 
(ºC) 
NAAPC ATCACCATGGTGATGCTGAAGAAG 24 64 
APPCTERMIII GTGGCCCCGGGCTAGTTCTGCATCTGCTCAAAG 33 86 
GAL4 AD TACCACTACAATGGATG  17 48 
GAL4 BD TCATCGGAAGAGAGTAG  17 50 
Amplimer 3’ 
(reverse)  
ATCGTAGATACTGAAAAACCCCGCAAGTTCAC                                                                                                                               32 84
Amplimer 5’ CTATTCGATGATGAAGATACCCCACCAAACCC 32 94 
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 Appendix III - Bacteria and yeast strains 
 
- E. coli XL1- blue: recA endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac[F’ proAB 
lacZ? M15 Tn10(Tetr)] 
 
- S. cerevisiae AH109: MATa, trp1-901, leu2-3, 112? ura3-52, his3-200, gal4? , gal 
80? , LYS2:: GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-
MEL1TATA-lacZ, MEL1 
 
- S. cerevisiae Y187: MATa? ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, 
gal4? , met-, gal 80? , URA3:: GAL1UAS-GAL1TATA-lacZ, MEL1 
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 Appendix IV - Plasmids 
 
 
 
 
 
 
Figure 1: pACT2 (CLONTECH) map and MCS. Unique sites are coloured blue. pACT2 is 
used to generate a hybrid containing the GAL4 AD, an epitope tag and a protein encoded 
by a cDNA in a fusion library. The hybrid protein is expressed at medium levels in yeast 
host cells from an enhanced, truncated ADH1 promoter and is target to the nucleus by 
the SV40 T-antigen nuclear localization sequence. pACT2 contains the LEU2 gene for 
selection in Leu- auxotrophic yeast strains. 
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Figure 2: pAS2-1 (CLONTECH) map and MCS. Unique sites are coloured blue. pAS2-1 is 
a cloning vector used to generate fusions of a bait protein with the GAL4 DNA-BD. The 
hybrid protein is expressed at high levels in yeast host cells from the full-length ADH1 
promoter. The hybrid protein is target to the yeast nucleus by nuclear localization 
sequences. pAS2-1 contains the TRP1 gene for selection in Trp- auxotrophic yeast strains. 
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